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“Do not be afraid of growing slowly, be afraid of just standing” 
        Chinese proverb 
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RESUMO 
Introdução: A esclerose múltipla (ES) é considerada uma doença do sistema nervoso 
central, complexa e heterogénea desde o ponto de vista clínico. A etiologia da ES é 
controversa e os mecanismos moleculares subjacentes não são totalmente conhecidos. A 
disfunção na marcha é um dos sintomas mais debilitantes na ES. Aproximadamente 85% 
dos doentes indicam que os problemas da marcha são uma das maiores limitações no 
seu dia-a-dia.  
A acupunctura, como uma forma terapêutica da Medicina Tradicional Chinesa (MTC), 
regula as funções vegetativas para manter a homeostasia mediante a estimulação de 
mecanismos de autorregulação. Em alguns estudos de acupunctura foi encontrado uma 
redução da espasticidade e melhoria da fadiga e desequilíbrio em doentes com ES, mas 
há uma grande lacuna relativamente à marcha. 
 
Material e Métodos: Baseado no modelo de Heidelberg de MTC, foi desenhado um 
estudo prospectivo, randomizado e controlado com o intuito de melhorar os problemas da 
marcha em doentes com ES. A nossa amostra consistiu em 20 indivíduos, todos eles 
com diagnóstico de ES do tipo surto-remissão (RRMS). Os problemas da marcha foram 
avaliados pelo teste T25FW (25-Foot test), que mede o tempo utilizado para caminhar 
uma distância fixa, e é recomendado para ensaios clínicos em ES. O mesmo teste foi 
realizado mas na forma “pé ante pé”. Os doentes foram randomizados de forma cega em 
dois grupos (A e B). A intervenção em acupunctura foi realizada em dois momentos: num 
primeiro momento, os doentes do grupo A receberam o tratamento de acupunctura 
verdadeira, utilizando os pontos ST34, BI40 e BI57, e os doentes do grupo B receberam o 
tratamento de acupunctura falsa. Num segundo momento, o grupo A recebeu a 
acupunctura falsa e o grupo B a verdadeira. Antes e depois de cada tratamento, a 
marcha foi avaliada. 
 
Resultados: Relativamente aos resultados do 25-Foot test, a comparação dos resultados 
antes e depois do tratamento de acupunctura mostraram diferenças estatisticamente 
significativas (p<0.05) na acupunctura verdadeira, quando comparado com a acupunctura 
falsa. Também encontramos que usando acupunctura verdadeira, 95% dos casos 
mostraram uma melhoria no T25FW test, comparado com um 45% quando a acupunctura 
falsa foi realizada. Na forma pé-ante-pé foram encontrados resultados significativos em 
ambos os tratamentos de acupunctura. 
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Conclusões: Os resultados obtidos no presente estudo apoiam a ideia de que o teste 
T25FW apresenta suficiente sensibilidade para avaliar o efeito do tratamento, e portanto 
é uma ferramenta útil como uma medida clínica da marcha em estudos que envolvam 
acupunctura. Os resultados do teste pé-ante-pé indicam possivelmente que o equilíbrio 
poderá depender mais da motivação ou expectativas do doente. O nosso protocolo 
proporcionou evidências de que o tratamento de acupunctura, de acordo com o modelo 
de Heidelberg de MTC, pode resultar em melhorias na mobilidade. Isto faz da 
acupunctura, uma alternativa válida para a intervenção em doentes com ES com 
problemas da marcha que procuram uma terapia eficiente. 
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SUMMARY 
Introduction: Multiple sclerosis (MS) is considered a disease of the central nervous 
system, complex and heterogeneous from the clinical point of view. The aetiology of MS is 
controversial and the underlying molecular mechanisms are still not completely 
understood. Gait dysfunction is one of the most debilitating symptoms in MS. 
Approximately 85% of patients indicate impaired gait as one of the major limitations in 
their daily life. 
 
Acupuncture, as a therapeutic form of Traditional Chinese Medicine (TCM), regulates the 
vegetative functions to maintain homeostasis by stimulating self-regulation mechanisms. 
In some acupuncture studies a reduction of spasticity and improvement of fatigue and 
imbalance has been found in MS patients, but there is a lack of studies regarding gait.   
 
Material and Methods: Based on the Heidelberg model of TCM, an acupuncture 
prospective, randomized and controlled study in cross-over design was done in order to 
improve gait problems in patients with MS. The sample consisted of 20 individuals, all of 
them with a diagnosis of MS of relapse-remitting type (RRMS). Gait impairment was 
evaluated by the T25FW (25-Foot test), a timed walking over a fixed distance measure, 
recommended for clinical trials in MS. The same test was also done in a tandem walking 
way. Patients were blinded and randomized into one of two groups (A and B). The 
acupuncture intervention was divided into two moments: in the first one, group A of 
patients received a true acupuncture treatment, using ST34, Bl40 and Bl57 points, and 
patients of group B received sham acupuncture treatment. At a second time, group A 
received sham acupuncture and group B true acupuncture. Before and after each 
treatment, gait impairment evaluation was done.  
 
Results: The results of the 25-Foot test, comparing before and after acupuncture, showed 
statistically significant differences (p<0.05) in true acupuncture, when compared with 
sham acupuncture. We also found that when using true acupuncture, 95% of cases show 
an improvement in T25FW test, compared to 45% when sham acupuncture was done. 
Tandem walking test revealed significant results in both acupuncture treatments. 
 
Conclusions: The results obtained in the present study can support the idea that the 
T25FW test is sufficiently sensitive to assess the effect of treatment and so can be a 
useful tool as a clinical measure of gait in studies involving acupuncture. The results of 
tandem walking test possible indicate that balance may depend more on individual 
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motivation or expectations. Our study protocol provides evidence that acupuncture 
treatment, according to Heidelberg model of TCM, can result in improvements in mobility. 
This makes acupuncture an attractive option for intervention for MS patients with gait 
impairment looking for effective therapy. 
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1.1 Multiple Sclerosis 
 
1.1.1 Introduction 
Multiple sclerosis (MS) is an inflammatory, demyelinating neurodegenerative disease of 
the central nervous system (CNS), considered as the most common cause of chronic 
neurological disability in young adults (Farias, 2014). MS affects more than 2.5 million 
people worldwide (Greenstein, 2007). Most MS patients are diagnosed between the ages 
of 20 and 50. Risk is greater in women than in men, being the female-male ratio between 
1.5 and 2.5 in most populations, with a trend towards higher values (Ascherio et Munger, 
2007). 
 
In multiple sclerosis, the loss of myelin (demyelination) is accompanied by a disruption in 
the ability of the nerves to conduct electrical impulses to and from the brain, what 
produces the various symptoms of MS. The sites where myelin is lost (plaques or lesions) 
appear as hardened (scar) areas. These scars appear at different times and in different 
areas of the brain and spinal cord. 
 
At the present time, there are no symptoms, physical findings or laboratory tests that can, 
by themselves, make the diagnosis of MS. It is necessary a careful analysis of the patient 
medical history and rule out other possible causes, as there are symptoms of MS common 
to other pathologies of the nervous system. Usually, the diagnosis is made according to 
Mc’Donald criteria, combining clinical manifestations and neurologic exam with various 
tests including magnetic resonance imaging (MRI), evoked potentials (EP) and spinal fluid 
analysis (European Multiple Sclerosis Platform, 2014). 
 
Mainly due to its social impact, intensive research is done to elucidate the underlying 
aetiology and pathogenesis of the disease. Although important advances in our 
understanding of the cellular and molecular aspects of MS have been achieved, there is 
still a long way to a comprehensive approach that will uncover treatment and symptom 
management therapies for everyone (Proceedings of the EPMA World Congress, 2014). 
 
Since MS is a chronic debilitating disease, it imposes enormous costs on patients and on 
health services. The physical symptoms of the disease and the resulting limitations are 
associated with strong social and economic impacts, such as reduced productivity, 
absences from work and a significant economic burden on affected families and the 
budget of the health system. These consequences are sharpened by the relatively young 
age of patients in which the disease manifests. In the recent study by Mateus (2010), the 
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total expenses per year for a patient with MS relapsing-remitting, with a degree of 
disability of 6.5 (EDSS), amount to 24199€. This amount includes treatment of disease, 
treatment for side effects, hospital admissions and ambulatory expenses. This figure does 
not include the indirect costs of the disease, which are estimated to be almost 40% of the 
total. 
 
Taking into account these figures and the current socio-economic context in Portugal, it 
would be of interest to introduce into primary health care complementary therapies for 
treating the symptoms of MS, less expensive and with fewer side effects than current 
ones. Of course this will require that national health authorities must ensure safety and 
competence in their use (WHO, 2010). 
 
1.1.2 History 
The wide variety and unpredictability of symptoms has made MS a difficult disease to 
recognize, define, and treat. Since the late 1300s, individuals with a progressive illness 
suggestive of MS have been observed, but it wasn't diagnosed until 1868 that the famous 
neurologist Jean-Martin Charcot lectured on the features of MS and gave it a name. 
Multiple sclerosis was officially recognized as a disease in the 1870s (Multiple Sclerosis 
Association of America, 2014). Some cases were diagnosed in Europe and United States, 
but for almost half of a century it continued to be considered as a rare disease.  At the 
beginning of the XX century the term “Multiple Sclerosis” was introduced in Germany but 
was only well-established in the middle of the century. Walter Moxen and Edward Seguin 
found that multiple sclerosis affected females more often than males and also determined 
that MS was not strictly genetic (Multiple Sclerosis Association of America, 2014). 
 
In 1935, the pieces of the MS puzzle started to come together. Thomas Rivers 
proved, through experiments with lab animals, that MS was not a viral disease, but one of 
the immune system. Still, only in the 1960s there was the idea that the immune system 
attacked the myelin coating of the nerves, and thus acted like an autoimmune disease. In 
1965 George Schumacher and a group of experts established criteria for the diagnostic. 
These criteria were replaced in 1983 by the ones of Poser, which integrated TAC imaging 
and cerebrospinal fluid laboratory data. Poser criteria were used until 2001 when they 
were replaced by McDonald’s. These criteria, which emphasize the visible alterations on 
MRI, were updated in 2005 in order to enable an early diagnostic and settings of relapse, 
spread and positive MRI (Bigotte de Almeida, 2010).  
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The first clinical trial for acute relapsed was performed in 1970. It evaluated the efficacy of 
the ACTH in the stimulation of corticosteroids in order to obtain an anti-inflammatory and 
immunosuppression effect. The 1990s could be named the “drug explosion” decade in 
terms of MS treatments. Interferon was approved as a treatment for relapsing-remitting 
MS and cortisone was used to treat MS relapses (Multiple Sclerosis Association of 
America, 2014). In 2004 was introduced the first selective inhibitor of adhesion molecules 
(Natalizumab) with the finality to block the entrance of inflammatory factors in the nervous 
compartment (Bigotte de Almeida, 2010). 
 
The new millennium brought new theories and the amount of information available about 
MS has grown exponentially in recent times. Nevertheless, more research is still needed 
to continue to find a cure for this chronic, unpredictable disease. Better treatments to 
prevent further progression and to repair the nervous system and restore function, and 
better management of symptoms must be a high priority to improved quality of life for 
people who live with MS every day. 
 
1.1.3 Epidemiology and risk factors  
Multiple sclerosis is probably one of the most studied neurological diseases from the 
epidemiological point of view. However, doubts remain about the real prevalence and 
incidence of MS. 
 
In 1975, Kurtzke introduced the concept of "latitude gradient" based on the fact that the 
prevalence of MS increases with distance from the equator in both hemispheres (Kurtzke, 
1977). According to this concept MS would be more common in Europe, North America, 
Australia and New Zealand, with prevalence higher than 50 per 100,000 populations. On 
the contrary, it would be rare in the East and infrequent in Africa and South America. 
However, recent epidemiological studies do not support this view of the worldwide 
distribution of multiple sclerosis. Population studies conducted in Italy showed prevalence 
rates much higher than the original figures (40-70 per 100,000) (Maddestra, 1998). Also, 
in Spain prevalence rates of 32-65 per 100,000 have been found (Uria et al, 1997). In 
Portugal, a study of De Sa et al. (2006) found a prevalence of 46.3 per 100,000. Another 
study performed in 2011 revealed a prevalence of 54 per 100,000 (Pinheiro and 
Guimarães, 2011) and more recently, in 2012, a study in the region of Lisbon showed a 
prevalence of 41.4 per 100,000 (De Sá et al, 2012). Thus, the distribution of multiple 
sclerosis in Europe, and in the world in general, seems to be more complex than 
previously thought. There are important differences in prevalence between areas with the 
same latitude and even within the same country (Pugliatti et al, 2006). Several studies 
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have also reported increasing incidence over time, although these data can be biased by 
heightened awareness of the disease and new diagnostic techniques (Compston and 
Coles, 2008). 
 
The geographical distribution of MS, especially with respect to latitude, raises the question 
if climate factors could be a causative factor of MS. In that sense, a correlation between 
solar radiation and a reduced risk of MS in several regions has been documented, while 
other studies have not found such association. Some studies have confirmed that sun 
exposure was consistently associated with a lower risk of MS (van der Mei et al, 2003). 
Taking into account that ultraviolet light promotes the production of vitamin D, the 
mechanisms of favourable effects of vitamin D in MS are not entirely known, but could be 
related to the ability of 1.25(OH)2D3 to inhibit the production of the Th1-associated 
cytokines interleukins-12 and 2, interferon- and TNF-, thus suppressing the 
development and proliferation of the inflammatory Th1 cells (Lemire et al, 1995; Munger et 
al, 2004).  
 
Although little is known about the aetiology of the MS, it is highly unlikely that the disease 
results from a single causative event. According to current knowledge, genetic and 
environmental factors are involved in its pathogenesis (Farias et al, 2014). As is the case 
for most neurodegenerative diseases, there is strong evidence to support the idea that MS 
is a disease with a complex genetic background upon which environmental triggers act. 
Studies in different countries have clearly shown that first-degree relatives of patients with 
MS have an increased risk of developing the disease. Also, studies of monozygotic twins 
with MS have shown that the monozygotic twin of a MS patient has more than 100-fold 
higher risk than the general population (Sadovnick et al, 1996). It has been proposed that 
the inheritance of MS is multigenic and affected by multiple loci (Holmes et al, 2005; 
Sawcer, 2006). Although these results suggest the presence of a genetic component, they 
also show a further important contribution of environmental factors.  
 
In spite of an intensive search in recent decades of genes related to multiple sclerosis, the 
only consistent association refers to the class II alleles of the Human Leukocyte Antigen 
(HLA), which is part of the major histocompatibility complex (MHC) region, particularly 
HLA-DR2 haplotype, HLA-DRB1 and HLA-DQB1 alleles (Veloso, 2010). An association 
with class I alleles, also initially proposed, is less consistent. A study of genomic 
association published by the International Multiple Sclerosis Genetics Consortium (2007) 
has shown that the HLA-DR locus is associated with MS. An association with alleles of the 
receptors of Interleukin-2 (IL2RA) and Interleukin-7 (IL7RA) was also found. As these 
Effects of Acupuncture on Gait of Patients with Multiple Sclerosis 
 
 27 
 
alleles have also been implicated in the pathogenesis of other diseases, such as Type I 
diabetes and Graves' disease, these results gave additional evidence that MS is an 
autoimmune inflammatory disease. 
 
Although genetic predisposition can probably contribute to geographical variations in the 
distribution of MS, it does not explain the differences in risk observed among populations 
who migrated from areas of low to areas of high disease prevalence, and vice versa. For 
example, in South Africa, the prevalence of MS is relatively high among European and low 
among African immigrants. Apparently, those who migrated from Europe into adulthood 
carried the high prevalence of their country of origin, while those who immigrated in 
childhood show a similar prevalence of local population (Compston and Coles, 2008). 
With respect to immigration to areas of high prevalence, children born in the UK of 
African, Asian and West Indian origin had a prevalence of MS similar to the equivalent 
Caucasians age groups (Elian et al, 1990). Thus, studies with migrants suggest that 
exogenous factors have a significant influence in the development of MS and that 
environment exposure would be particularly relevant in adolescence, although it is not 
clear whether these factors act as a trigger of the disease or are involved in its 
pathogenesis. In this context it has been suggested that infection could be an important 
agent, particularly early infectious diseases like measles, rubella, mumps and varicella. 
Nevertheless, epidemiological studies do not support a clear association between these 
diseases and MS (Ruth, 2004). 
 
Epidemiological findings of a latitude gradient, the apparent protection for MS individuals 
born in low-risk areas who migrate to areas of high-risk and a higher incidence of MS 
among groups of higher economic level and education, could be explained by the idea 
that, to develop normally, the immune system needs to be stimulated early in the 
individual's life (Veloso, 2010). In developed countries, vaccination, the widespread use of 
antibiotics and a better health care reduce infections in childhood; as a result, there would 
be a greater tendency to develop autoimmunity later in life (Bach, 2002). However, the so-
called “the hygiene hypothesis” is contradicted by the role that some infections have in 
autoimmunity, namely the association between infection by Eptein-Barr virus (EBV) and a 
significant increased risk of MS (De Jager et al, 2008). 
 
Ascherio and Munch (2000) gave evidences that almost all MS patients (>99 %) are 
infected by EBV, compared with about 90% of the control population. Other studies have 
confirmed an increased risk of MS after infectious mononucleosis (Thacker et al, 2006). 
Also, it seems that an association between disease activity and reactivation of the virus 
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exists. Association of other neurotropic viruses, such as the Herpes Types I and VI, with 
MS have also been found, suggesting that multiple agents may play a role in the 
pathogenesis of MS and the clinical course of the disease, presumably by immune 
mediation mechanisms (Veloso, 2010; Ascherio and Munch, 2007). 
 
In summary, MS is a very complex disease, probably due to an interaction of genetic and 
environmental factors. Existing biological and epidemiological data seems to confirm the 
existence of genetic susceptibility to MS, making also clear the importance of 
environmental factors among which stand out the sunlight/vitamin D and infectious 
agents, including Epstein-Barr virus. 
 
1.1.4 Physiopathology 
Classically, multiple sclerosis has been known as an autoimmune disease. Although the 
involvement of the immune system in the physiopathology of the MS seems to be evident, 
it remains unclear in what extent MS is an autoimmune or just an immune mediated 
disease (Fontoura, 2010). Recent literature and in vitro and in vivo studies have shown 
that there are other factors involved in the pathogenesis of the disease and there is not a 
unique cause. In other words, multiple sclerosis is a multifactorial disease (Bolaños-
Jimenez et al, 2011). 
 
Inflammation, demyelination and remyelination, oligodendrocyte depletion and neuronal 
and axon degeneration are the major pathologic mechanisms that leads to the formation 
of the sclerotic plaque, the hallmark of a demyelinating disease like MS. However, the 
order and relation of these parts of the process remain unclear.  
 
The blood-brain barrier (BBB) is an anatomical and functional barrier that protects the 
encephalon against microorganisms, toxins and other agents. In multiple sclerosis, there 
is a disruption of this barrier, allowing lymphocytes and other cells and factors involved in 
inflammation, namely molecules of the major histocompatibility complex (MHC) class II, 
citokines, immunoglobulins, complement molecules and nitric oxide, to enter the central 
nervous system and start the inflammatory process (Bolaños-Jimenez et al, 2011). 
Activation of T CD4+ cells in the periphery and subsequent generation of Th1 is the first 
step of the process. These autoreactive T cells interact with adhesion molecules on the 
endothelial surface of the CNS and cross the disrupted BBB with the aid of matrix 
metalloproteinases and chemokines. B cells and monocytes are also involved. The failure 
of local regulation of these immune components, by either receptor activation or cytokine 
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release, triggers the pathogenic process at particular sites of inflammation dominated by 
cell infiltrates (Figure 1). 
 
Inflammation seems to be driven by T helper 1 (Th1) and the subtype that secretes 
interleukin-17 (Th17) under interleukin-23 control (Kebir et al, 2007; Tzartos et al, 2008). 
Which antigen starts this response is an unknown matter up to now, but putative antigens 
include myelin basic protein, myelin-associated glycoprotein, myelin-oligodendrocyte 
glycoprotein, proteolipid protein, ab-crystallin, phosphodiesterases and S-100 protein 
(Tullman, 2013). 
 
The central role of Th17 produced citokines in the brain is the induction of inflammation 
characterized by immune cells recruitment, enhancing microglia activation and myelin loss 
(Iwakura and Ishigame, 2006). As immune cells accumulate, pro-inflamatory citokines like 
IL-2, IL-23, interferon , TNF amplify the immune response. Together with these 
inflammatory citokines, proteases, free radicals, antibodies, nitric oxide, glutamate and 
other stressors that collectively lead to damage of myelin and oligodendrocytes are also 
involved (Tullman, 2013). Besides pathogenic lymphocytes, some regulatory cell 
populations with an important role in the control of the autoimmune response, are present. 
That is the case of the Treg T CD4+cells. Some studies verify the suppressor potential of 
these cells on the inflammatory process, but although these cells are present in 
demyelinised lesions, their function is not enough to antagonize the effect of other cell 
populations (Korn et al, 2007). 
 
Contact is established between activated microglia and components of the 
oligodendrocytes-myelin unit that is opsonised with ligands for microglial Fc and 
complement receptors. Cell surface bound TNF- which constitutes a lethal signal 
(Compston and Coles, 2008) (Figure 1).  
 
The demyelination process represents an initial phase of the chemical lesion, with 
dissolution of myelin by antibodies and complement factors. The presence of IgG capping 
of macrophages suggests that antibody-mediated phagocytosis of myelin may play a role 
in the pathogenesis of the disease (Greenstein, 2007). Then, desegregation of the myelin 
forms spheroids that are removed by macrophages. The lesion enters in a chronic phase 
in which the inflammation and demyelination stops. The plaque reveals at this moment 
loss of oligodendrocytes. These cells seem to die through necrosis and apoptosis (Figure 
1). 
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Luchicetti et al. (2011) described four different patterns of demyelination in MS, taking into 
account: the distribution of myelin loss, the geography of the plaques, the extension and 
pattern of destruction of oligodendrocytes and IgG deposition evidence and activation of 
complement. The most common type, pattern II, was characterized by the deposition of 
immunoglobulin and complement. Pattern I was characterized by macrophage-associated 
demyelination. In patterns III and IV, demyelination was due to oligodendrogliopathy. 
Pattern III was differentiated from pattern IV by a preferential loss of myelin-associated 
glycoprotein. In the same individual, all lesions have only one of these four patterns, but 
there was marked heterogeneity between patients, suggesting that MS might have 
multiple pathogenic mechanisms (Tullman, 2013). 
 
 
Figure 1: Schematic representation of pathogenesis of demyelinating lesions in MS. Adapted from 
Fontoura (2010). 
 
In 20% of MS patients plaques are eventually remyelinated. Remyelination happens 
because the mature nervous system maintains a pool of oligodendrocytes precursors that 
can surround the lesions and presumably act as the source of cells having the potential to 
remyelinate naked axons (Chandran et al, 2008). Nevertheless, successive cycles of 
demyelination and remyelination can exhaust the capacity for tissue repair. 
 
T and B cells, as well as macrophage activity, are responsible for tissue injury. 
Lymphotoxins and TNF- are cytotoxic to oligodendrocytes. Nitric oxide leads to necrotic 
death of oligodendrocytes, reversible conduction block in axons, inhibition mitochondrial 
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respiration, increasing intra-axonal Na+ and activating the Na+/Ca++ exchanger, which 
triggers a cascade leading to axonal degeneration (Greenstein, 2007).  Elevated 
glutamate levels are present in active MS lesions and it is also involved in the damage to 
oligodendrocytes, myelin and axons (Micu et al, 2006). 
 
Remodelling of the axonal membrane both during acute and chronic demyelination is 
present and probably contributes to the development of axonal degeneration. As 
alterations in Na+ channels occurs, Ca++ entries into axons with subsequent production of 
injury. The increase in axoplasmic Ca++ activates proteases fragmenting neurofilaments 
and depolymerizating microtubules (Stys, 2004). Also, reduced mitochondrial respiratory 
complex I activity is present in chronic active MS lesions (Lu et al, 2000). The reduced 
activity of mitochondria leads to decreased ATP production, which can be an additional 
factor leading to axonal degeneration (Dutta et al, 2006). Oligodendrocytes provide trophic 
support for axonal function that fails when some myelin proteins are lost.  
 
The resulting transient dysfunction of demyelination explains the symptoms and signs 
present during the clinical relapses, while axonal injury is responsible for the progressive 
and irreversible clinical worsening characterizing the two types of clinical evolution 
(relapses and progression). 
 
Further studies are needed to understand the complexity and heterogeneity of the 
immunopathogenesis of the disease. The pathologic variability indicates MS clinical 
variability and reinforces the need of new treatment strategies that includes preventing 
axonal loss and the inflammatory process due to lymphocytes T and macrophages. 
Demyelination must be avoided by acting in the process antibody-complement and 
inhibiting proinflamatory citokines. It is also necessary to promote the remyelination, 
induce the oligodendrocytes and stimulate Th2 suppression citokines.  
 
1.1.5 Clinical Manifestations 
The clinical manifestations of MS are highly variable and unpredictable. There are no 
clinical findings that are unique to MS, but some are highly characteristic of the disease. 
About 80% of patients present a “clinically isolated syndrome (CIS)”, term used to 
describe a first episode of neurologic symptoms, that lasts at least 24 hours, in one or 
more sites in the central nervous system. CIS can be either monofocal or multifocal, 
depending if a single neurologic symptom is present, or more than one. Individuals that 
experience a CIS may develop MS. When CIS is accompanied by MRI-detected brain 
lesions, similar to those seen in MS, the person has a high likelihood of a second 
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neurologic event and a diagnosis of MS within some years. When CIS is not accompanied 
by MRI-detected lesions, the person has a lower likelihood of developing MS (National 
Multiple Sclerosis Society, 2014). 
 
According to the National Multiple Sclerosis Society (2014) the most common symptoms 
of MS include: vision problems, fatigue, numbness and tingling, weakness, dizziness and 
vertigo, pain, sexual problems, emotional changes, gait difficulties, spasticity, bladder and 
bowel problems, cognitive problems and depression. Less common symptoms include: 
speech problems, tremor, breathing problems, headache, swallowing problems, seizures, 
itching and hearing loss. 
 
Sensory symptoms 
The most common initial symptoms largely reflect the involvement of sensory, motor and 
autonomic pathways in the brainstem/cerebellum and the optic nerve. One of the most 
common symptoms is the presence of numbness or paresthesias in a member. Typically, 
changes in sensitivity are noted in distal regions, then progressing to the proximal 
segments and side members. Symptoms are commonly described as numbness, tingling, 
pins-and-needles, tightness, coldness or swelling of the limbs or trunk. 
 
Pain is a common disease manifestation throughout the disease. In the study of O'Connor 
et al. (2008), the estimated prevalence of pain is 50%. The pain can be caused directly by 
the demyelinating lesions (primary) or be related to the physical limitations of the disease 
or treatment (secondary). The diversity of the causes of pain makes it difficult to classify, 
being generally categorized according to the underlying pathogenic mechanisms: 
neuropathic pain vs musculoskeletal, an important distinction for selecting the most 
appropriate treatment (Pollmann and Feneberg, 2008). Also, the coexistence of different 
types of pain is rather common. 
 
The Lhermitte phenomenon is described as an electric shock radiating down the spine or 
into the limbs with flexion of the neck. This symptom happens in up to 40% of the patients 
throughout the course of the disease, but it can also be seen in other lesion of the cervical 
cord (Kanchandani and Howe, 1982). 
 
Motor symptoms 
The motor symptoms are less common than the sensitive ones, but have more serious 
consequences, representing the leading cause of disability in progressive stages of the 
disease. Deficits result from the involvement of pyramidal pathway (cortical-spinal and 
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cortico-bulbar descending pathways) by lesions with a hemispheric or medullary location. 
The pyramidal signs are among the most common abnormalities in patients with MS. They 
are often bilateral and asymmetrical. The worsening of muscle weakness is associated 
with spasticity, which generates increased difficulties to gait and posture. The increased 
tone in the extensor muscles can determine the presence of spasms, particularly in the 
cubital position and at the beginning of the movement. Spasticity significantly worsens 
with the onset of pressure ulcers and urinary tract infections.  
 
For movement disorders, tremor of action and dyskinesia or paroxysmal tonic spasm is 
common. A prevalence of 37% of tremor and 20% of tonic spasms was described by Vale 
(2010).  
 
The cerebellar symptoms are common in MS, usually appearing some years after the 
onset of the disease. Gait imbalance, difficulty in performing coordinated actions with the 
arms and slurred speech may occur as a result of impairment of cerebellar pathways. 
Cerebellar signs are usually mixed with pyramidal (cortical-spinal) tract signs (Olek, 2014). 
 
Visual symptoms 
Optic neuritis (ON) is the most common type of involvement of the visual pathways in 
relapse-remitting form of MS. Optic neuritis is present as an initial manifestation in 20% of 
the cases (Confavreux et al, 2003). 
 
Typically ON manifests by acute loss of monocular vision associated with local pain. Pain 
precedes or accompanies the visual complains. It is referred to the orbital or frontal-orbital 
region and significantly worsens with eye movement and pressure of the eyeball. Vision 
loss settles in hours or days and a greater commitment of central vision (scotoma) is 
noted. The degree of vision loss is very variable. When vision is relatively preserved, 
colour vision and contrast sensitivity are the most altered. Other symptoms may be 
photopsias and sometimes a feeling of visual distortion when in motion, a phenomenon 
associated with the presence of different driving speeds in optical pathways (Burke et al, 
2001). 
 
Physical examination of patients with ON reveals a relative afferent pupillary defect 
(Marcus Gun pupil). Disc oedema may be observed on fundus examination. Most often 
the lesion of the optic nerve is retro-bulbar, and fundus examination is normal in the acute 
stage. Later, the optic disc becomes pale as a result of axonal loss and resultant gliosis. 
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90% of patients recover vision over a period of two to six months after an acute episode of 
ON (Olek, 2014). 
 
MS can cause a wide variety of ocular-motor changes, the inter-nuclear ophthalmoplegia 
(INO) and cerebellar changes of the look being the most frequent. Inter-nuclear 
ophthalmoplegia refers to abnormal horizontal ocular movements with lost or delayed 
adduction and horizontal nystagmus of the abducting eye. A bilateral INO in a young adult 
represents the most characteristic signal of MS, but it can be observed in other intraaxial 
brainstem lesions (Olek, 2014). 
 
Sphincter/sexual dysfunction 
Bowel, bladder and sexual dysfunction are common in MS. 
 
The alterations of the bladder control are mainly related to the presence of lesions in the 
hypothalamus, brainstem and spinal cord, which interrupt the central control circuits and 
the sympathetic and parasympathetic pathways (Vale, 2012). The most common 
symptom is urinary urgency, reported by 75% of patients and associated with a persistent 
increase in detrusor activity which causes a reduction in bladder volume. This increases 
the frequency of urination with nocturia and urinary incontinence appears (Haensch and 
Jorg, 2006). In other cases the complaints relate to the difficulty of emptying. In these 
cases, there is a simultaneous activation of mechanisms that empties the bladder and 
those that close the sphincter due to the spinal cord injuries. The residual volume also 
increases, causing incontinence. There are also frequent recurrent urinary tract infections, 
particularly in women, that may increase the extent of bladder dysfunction. The frequency 
of urinary symptoms increases with age and disease duration and is often associated with 
spasms of the lower limbs (de Sèze et al, 2007). 
 
The majority of MS patients refer also alterations in bowel function: faecal incontinence 
and constipation. Constipation is more common than faecal incontinence. These problems 
may be a result of both upper and lower motor neuron impairment, in addition to a 
decrease in general mobility. 
 
Sexual activity is often altered in patients with MS, independently of gender. The disability 
associated with the disease leads to difficulties in the affective relationship and sphincter 
dysfunction. Changes in sensation, pain and spasticity of the lower limbs and pelvic floor 
directly interfere with sexual performance. The most frequent alteration identified is 
erectile dysfunction, which affects about 40% of patients with less than 30 years old 
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(DasGupta and Fowler, 2002); decreased libido and inability to achieve orgasm are also 
common (Nortvedt et al, 2007). 
 
Fatigue 
Fatigue is defined as a feeling of lack of physical or mental energy that interferes 
significantly with the performance of daily activities. It affects about 85 to 90% of patients 
that referred it as the most disabling symptom of the disease. It is characterized as a 
feeling of exhaustion, weakness or excessive sleepiness that tends to follow a circadian 
rhythm and is accentuated with heat (Uthoff phenomenon) and physical activity. Fatigue 
can manifest at any stage of the disease and seems to be determined by a decrease in 
voluntary muscle activity by bankruptcy of the central mechanisms that generate motor 
activity (Greim et al, 2007). 
 
Cognitive dysfunction 
Although cognitive changes have been described by Charcot in the first descriptions of 
MS, only from the last few decades they are no longer regarded as a minor manifestation 
of the disease. It is currently reported a 45-65% of patients with cognitive disorders that 
has a major impact on their quality of life (Calabrese, 2006). The clinical presentation is 
variable and may range from mild cognitive impairment to a rare case of severe disability 
(Piras and Solinas, 2003). They can be found from the early stages of the disease and 
may have a variable course (Kujala et al, 1997).  
 
The functions most frequently affected are memory, attention, and speed of information 
processing and executive capacities. These changes can fit into a pattern of subcortical 
dysfunction due to multiple neuronal network disconnections in the presence of 
demyelinating lesions (Calabrese 2006).  
 
Neuropsychological assessment allows to quantify the nature and severity of cognitive 
deficits, which are not easily detected in routine consultations, and hence the need to 
include it as an additional study in the framework of a multidisciplinary clinical evaluation 
component (Silva, 2012). 
 
Depression is the most common psychiatric manifestation in MS. Some authors indicate 
that it can affect nearly 50% of patients over the disease. It is believed that it has a 
multifactorial origin, but may also be related to the presence of persistent inflammation or 
with the localization of brain injury (Foong and Ron, 2003). 
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The symptoms of multiple sclerosis can be different from person to person. Visual, 
sensory, and motor signs and symptoms are all part of multiple sclerosis. The clinical 
manifestations are varied, and therefore there is a wide range of symptoms that can 
appear. Some people have mild cases of multiple sclerosis with little or no disability over 
the years. Others have more severe types, requiring confinement to a wheelchair or bed.  
 
1.1.6 Disease course 
The current MS classification system is based on consensus and relies on the clinical 
criteria since we do not have enough knowledge that enables an etiopathologic or 
physiopathologic classification (Pinto Marques, 2010). 
 
Clinically, the two basic events that mark the disease are relapse and progression. 
Relapse is defined as the occurrence, recurrence or worsening of a neurological 
dysfunction that has a duration equal or superior than 24 hours. After reaching the peak, 
the dysfunction stabilizes and is followed by a recovery that may be complete or partial. 
All neurological changes in a month will be considered as being the same relapse.  
 
The term progression in MS means a continuous worsening of symptoms for a period of at 
least 6 months. Periods of stabilization may occur or overlapping outbreaks.  
 
Currently, the following definitions of types of clinical disease progression are used 
(Lublin, 1996): Relapsing-remitting, primary-progressive, secondary-progressive and 
progressive-relapsing (Figure 2) 
 
Relapsing-remitting MS  (RRMS) 
This form accounts for 70% of patients with MS (Pinto Marques, 2010). It is characterized 
by acute relapses interspersed with periods of clinical remission that are characterized by 
a lack of disease progression.  
 
Primary-progressive MS (PPMS) 
This form is characterized by a progression of the disease from the onset. The rate of 
progression may be variable and there may exist periods of stabilization, but not well 
defined relapses occur. It accounts for about 10% of the cases. It is more frequent in older 
adults with the same prevalence in men and women (Tullman, 2013, Pinto Marques, 
2010).  
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Secondary-progressive MS (SPMS) 
It is characterized by progression after a period of evolution by relapses. The existing 
deficits cannot be explained only by the accumulation of the symptoms of relapses with 
incomplete recovery. There is a continuous deterioration of neurological functions. This 
form constitutes 15 to 20% of all forms at a given time (Pinto Marques, 2010). 
 
Progressive-relapsing (PRMS) 
Progressive-relapsing multiple sclerosis is characterized by progressive disease from 
onset, with clear acute relapses, with or without full recovery. Progression continues 
during the periods between relapses. This type of MS is the less common form of the 
disease being responsible for about 5% of the cases (Olek, 2014, Tullman, 2013). 
 
From this classification we can say that there are two ways for the clinical onset of the 
disease: relapse-remitting or primary-progressive. From these forms there may be or not 
evolution of the disease to secondary-progressive or progressive-relapsing, respectively. 
When we talk about a particular patient with a particular form of MS, this should be 
understood as a form of clinical manifestation of the disease at that time. The same 
patient may change its clinical presentation and later evolve into another form. Thus, it 
might be more correct to speak of clinical stages of the disease rather than forms of the 
disease (Pinto Marques, 2010). 
 
 
Figure 2: Types of clinical disease progression in MS. Adapted from 
www.medscape,com/features/slideshow/multiple-sclerosis (30 May 2014) 
 
1.1.7 Diagnosis 
Multiple sclerosis is a clinical diagnosis. There is no single test that is proof-positive 
for diagnosing MS. However, there are accepted criteria for making the diagnosis. The 
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diagnostic clinical criteria have evolved over time (Tullman, 2013). MS diagnostic criteria 
used were stablished in 2001 and revised in 2005 and 2010 (Polman et al, 2011). These 
criteria can be summarised by a matrix that aims to demonstrate four essential points:  
-Existence of lesions in the CNS;  
-Presence of these lesions in more than one region of the CNS, i.e. its spread in space;  
-Occurrence at different times, i.e. their dissemination in time;  
-Lack of another better explanation for the neurological abnormalities found than the 
diagnosis of MS (Sá, 2010a). 
 
Thus, the diagnosis of MS requires at least one episode of neurological dysfunction 
consistent with inflammation and demyelination that occurs in the absence of fever or 
infection. It must last at least 24 hours and present objective evidence of lesions 
disseminated in space and time that may be demonstrated clinically or by magnetic 
resonance imaging (Polman et al, 2011). 
 
An accurate diagnosis of multiple sclerosis is based on the medical history and a 
neurological exam using various tests. In addition, a variety of specialized procedures are 
helpful in accurately diagnosing MS. These include imaging techniques, such 
as MRI, spinal taps or lumbar punctures and examination of the cerebrospinal fluid, 
evoked potentials to determine if MS has affected a person's nerve pathways, and lab 
analysis of blood samples. Other possible conditions apart from MS must be excluded. 
 
The introduction of magnetic resonance and its subsequent technological developments 
have completely changed the diagnostic process in MS. The disease can be diagnosed 
with greater certainty and early (Barkhof et al, 2003). The RMI helps in the diagnosis of 
MS because it can show lesions with typical morphology and localization of the disease. 
At the same time it can show the spread in space and time and helps exclude other 
possible aetiologies (Pedrosa, 2010a). 
 
The study of cerebrospinal fluid (CSF) in MS allows to show the inflammatory nature of 
the disease. The parameters studied in the cerebrospinal fluid in patients with MS include: 
cell count, total protein and evaluation of the barrier blood/CSF, quantitative and 
qualitative analysis of the humoral response (in MS there is additional IgG synthesis in the 
subarachnoid space induced inflammation), analysis of markers of inflammation 
(cytokines, adhesion molecules, metalloproteinases), cell markers, antibodies and nitric 
oxide, markers of axonal lesion as neurofilamentar protein, actin and tubulin, tau protein, 
24S-hidrocolesterol or apoprotein E (Sá, 2010b). 
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The search for biological markers in MS has been the subject of intense research but 
there is no evidence to support the existence of a reliable marker in MS. In this regard it 
may be more informative the association of several markers that could establish a profile 
of the disease. 
 
The neurophysiological examination can be important to demonstrate clinically silent 
lesions, in some cases enabling patients to reclassify. The evoked potential is defined as 
consecutive modification of brain activity applying a sensory stimulus. Evoked potentials 
maintained their clinical utility as they can allow detecting lesions that are not apparent on 
the neurological examination and further demonstrate the axonal or demyelinating nature 
of these lesions. Mainly, visual evoked potentials are used but also the somatosensory, 
auditory, and cognitive analysis will also be useful (Alves, 2010)  
 
1.1.8 Therapeutics  
Although there is no cure for MS, there are some ways of managing the disease. 
Treatment of MS typically focuses on: 1) treating the relapses, mainly speeding recovery 
from them, 2) modifying the course of the disease, slowing its progression, and 3) 
managing symptoms, trying to slow the development of disability. 
 
Treating the relapses 
The treatment of the first manifestation of the disease or a new outbreak is done with 
corticosteroids at high doses. They reduce the severity and duration of symptoms. 
However, there are insufficient data to confirm whether there are long-term benefits with 
the use of corticosteroids. The most common treatment regimen is a three-to-five-day 
course of intravenous methylprednisolone. High dose oral prednisone may also be used.  
 
Glucocorticoids are powerful immunosuppressants. They have anti-inflammatory effect 
with a reduction of proinflammatory cytokines and induction of apoptosis of T cells, at the 
same time they regulate the permeability of the blood-brain barrier.  
 
Symptoms that may arise associated with the use of intravenous corticosteroids are: 
abnormal taste, oedema in the lower limbs, distal paresthesias, weight gain, acne, 
increased tendency to infections, insomnia, emotional disturbances, glycosuria or 
decompensation of prior diabetes (Pedrosa R, 2010b; National Multiple Sclerosis Society, 
2014). 
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Disease modulators 
Only in 1993 the first drug for the treatment of MS, interferon beta-1b (Betaferon ), was 
approved in the USA. In a randomized trial this drug significantly reduced disease activity 
in terms of reducing the number of relapses and measures of RM when compared to 
placebo (Batista et al, 2010). Later, the FDA approved an intramuscular formulation of 
interferon beta-1a (Avonex ) and in 2002 a formulation of subcutaneous interferon beta-
1a (Rebif ) was approved in Europe. Regarding the mechanisms of action of interferon, 
they are still not completely understood but, in addition to antiviral properties, it has 
immunomodulatory and antiproliferative activity, important in MS: inhibition of T 
lymphocyte proliferation and NK cell activity; regulating the expression of MHC molecules 
and alteration of cytokine production, among others. There are also evidences that 
suggest an effect of interferon in the preservation of blood-brain barrier with inhibition of 
metalloproteinases and reduction of cell migration (Hartrich et al, 2003, Shapiro et al, 
2003; Boz et al, 2006). 
 
The most common side effects of treatment with interferon are fever, myalgia and 
headache. Lymphopenia, leukopenia, neutropenia and elevated liver enzymes may also 
occur. The occurrence of local reactions at injection is also frequent and in 3-4% of cases 
skin necrosis happens. Treatment with interferon is contraindicated in pregnancy and 
discouraged in breastfeeding (Batista et al, 2010). 
 
Apart from interferon, between 1999 and 2003, glatiramer acetate (GA) (Copaxone ) 
appears. According to the most accepted theory, its use would promote Th2 cells 
response. When these cells are exposed to foreign antigens in the periphery mimicking 
myelin, they would trigger an immune response characterized by the production of anti-
inflammatory cytokines and possibly neurotrophic factors that regulate the immune 
response. Several studies in patients with RRMS showed a significant reduction in the 
number of relapses without worsening of EDSS disability and a reduction in the number of 
imaging lesions with few adverse reactions (Johnson et al, 2000; Comi et al, 2001). 
 
Treatment with intravenous human immunoglobulin (IVIG) assumed an important role in 
some neurological diseases. Among the proposed mechanisms for its activity in MS are: 
neutralizing autoantibodies against myelin proteins, decreasing production of autoimmune 
antibodies and blocking of Fc receptors of macrophages, promoting immunoregulation 
and attenuatiating complement activation (Sorensen, 2003; Kazatchkine and Kaveri, 
2001; Rodrigez and Miller, 1994). Reduction in the number of relapses, reduction of 
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imaging lesions and an improvement of disability were found in some studies but this 
trend was not observed in others. The conditions of the studies were not the same, what 
necessarily interferes in the findings (Batista et al, 2010). 
 
In recent years new molecules are being investigated in order to obtain more effective 
formulations with administration regimens more convenient and less incidence of adverse 
effects. Natalizumab is among drugs already approved and available in 2010. It is a 
monoclonal antibody that interferes with the migration of activated lymphocytes across the 
blood-brain barrier. Phase 2 and phase 3 assays show the benefits of the drug. Other 
monoclonal antibodies with promising results include: Alemtuzumab, Rituximab and 
Daclizumab (Freitas et al, 2010). 
 
Among the new oral therapeutic, Fingolimod  (FTY720) is a drug with immunomodulating 
properties, of daily oral administration, which has a different mechanism of action from 
classical immunomodulators. After phosphorylation, inhibits sphingosine-1-phosphate, a 
phospholipid mediator of numerous cellular functions. As a result, circulating lymphocytes 
are sequestered in lymph nodes with the consequent reduction in periphery and in the 
CNS recirculation (Kappos et al, 2006). In September of 2010 the drug was approved by 
FDA as first-line medication for relapsing-remitting MS (Freitas et al, 2010). 
 
As new drugs are being provided, the treatment of MS meets new challenges. The older 
drugs will be replaced by more recent ones with more specific mechanisms of action and 
fewer side effects. This will require a better understanding of the pathogenesis of the 
disease and early diagnosis in order to start treatment in early stages of the disease. 
 
Managing symptoms 
As previously mentioned, the disease modifying therapies in MS are used to reduce the 
frequency and severity of relapses and to delay progression and disability. But treatment 
of patients also requires strategies to control the symptoms and to prevent secondary 
complications and increased disability associated with disease. From the initial to the most 
advanced stages, the range of potential symptoms is vast and includes fatigue, spasticity, 
bladder dysfunction, ataxia, cognitive impairment, among others. Therefore, symptomatic 
treatment should be carefully planned and suitable for each patient. It must take into 
account that there may be an interaction between the symptoms and that the treatment of 
a symptom can aggravate other. Any approach must necessarily be multidisciplinary, 
involving the patient actively and include pharmacological and non-pharmacological 
therapies. 
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1.2 Gait in Multiple Sclerosis 
 
1.2.1 Definition 
Gait is a complex process involving coordination of multiple systems within the body 
(central nervous, musculoskeletal and cardiovascular systems). To walk, the nervous 
system must send signals to control a large number of muscles while simultaneously 
processing sensory information in order to monitor and refine movements, all this while 
maintaining an upright stance (Winter, 2009). Taking into account the great number of 
muscles and neural processes involved, gait variability probably arises from a combination 
of factors. 
 
Several studies reveal that gait variability is an indicator of walking function and that some 
characteristics of gait variability are associated with neural control of walking (Stergion et 
al, 2006). Increases in gait variability have been observed in elderly as well as various 
neurologically impaired populations such as Parkinson´s disease, dementia and multiple 
sclerosis (Socie and Sosnoff, 2013). 
 
1.2.2 Assessing walking disability 
Walking disability is a major feature of neurological diseases. Consequently, measure and 
assess walking disability is important in multidisciplinary teams. In clinical practice, the 
WHO international classification of functioning (ICF) is often adopted as the underlying 
framework for assessment of mobility (WHO, 2001). Different impairments end in 
abnormal or reduced walking. For instance, in multiple sclerosis, impairment such as 
weakness and spasticity from pyramidal lesions, loss of co-orientation from dorsal column 
and cerebellar lesions together with visual and cognitive dysfunction and pain can 
contribute to walking disability (Figure 3).  
 
Impaired disability can be also a marker of disease progression and an important outcome 
measure of treatment and rehabilitation programmes in diseases such as MS and 
Parkinson´s disease (Pearson et al, 2004). 
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Figure 3: Framework of international classification of function (ICF). Mobility in MS. Adapted from 
Pearson et al. (2004). 
 
Although assessing gait disability is of great importance in some pathologies, there is no 
consensus regarding the most appropriate tool for characterization of gait dysfunction 
(Kieseier and Pozzilli, 2012). According to Fisher et al. (1999) an ideal measure should be 
widely applicable, clinically meaningful, easy to administer, valid and reliable, provide 
reproducible results and be responsive to change.  
 
Self-reports 
The simplest way of gait assessment involves patient-reported measures or self-reports. 
They give the patient´s own perspective on the impact of walk impairment in their daily 
lives. Advantages of self-reports measures are that they are easy to perform and low in 
cost. The principal disadvantages are that patients can prioritize specific aspects and that 
their emotional state may be an influence during self-rating (Hobart et al, 2003). The most 
common of these reports is the Multiple Sclerosis Walking Scale 12 (MSWS-12). This 
survey consists of 12 questions that assess gait impairment in terms of the speed, 
distance and daily activities impact perceived by the patient. The MSWS-12 has been 
validated as a measure of walking function and as responsive to gait changes (Hobart et 
al, 2003; McGuigan and Hutchinson, 2004) and also as a measure of walking quality 
metrics (Pilutti et al, 2013). 
 
 
 
 
 
 
Health condition: type of pathology 
Pyramidal Dorsal Cerebellar 
Weakness Sensory Loss Ataxia 
Reduced Walking 
Impact on individual 
Personal factors: age, 
gender, copying style, 
attitude… 
Environmental factors: 
social attitudes, resources, 
climate… 
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Quantitative analysis 
Timing of walking 
Timed walking over a fixed distance has been extensively used as a clinical measure of 
gait in a variety of neurological conditions and form part of a recommended outcome 
measure for clinical trials in multiple sclerosis (Fisher et al, 1999). The main advantages of 
timed performance tests are that they are simple, quick and inexpensive, and allow data 
to be expressed in relation to a normal range, allowing the degree of deviation to be 
clearly seen. The main problem of these testes is a decrease in the reliability between 
tests, what lead some researchers to suggest that a range >20% is most likely to 
represent reliable change (Schwid et al, 2002), although this may differ depending on the 
population studied. The most common of timed performance tests is the 25-foot walk test 
(T25FW). In this test, person is directed to walk, as fast and safety as he/she can, across 
a clear marked linear 25 feet course. There are no turns, start is static and assistive 
device can be used. Also, 10-metre Timed Walk (10MTW), 30-meter Timed Walk 
(30MTW) and 100-meter Timed Walk (100MTW) are used. Shorter walking tests (T25FW, 
10MTW, 30MTW) represent good measures of overall walking ability and are suited for 
use in clinical setting (Gijbels et al, 2012). 
 
Endurance tests 
Endurance tests like 2mWT or 6mWT (2 or 6 minutes walking test, respectively) are used 
to measure the maximum distance that a person can walk over the time interval. 
According to Kieseier and Pozzilli (2012), 6mWT and 2mWT tests are good for 
assessment of walking fatigability, maximal walking distance limitation and functional 
capacity. In these tests the person is directed to walk for 6 (or 2) minutes at maximal 
speed, back and forth in a hallway turning at each end. Assistive devices may be used, 
rest is not permitted and encouragement is not allowed (Gijbels et al, 2011).  
 
Quantitative movement analysis 
The clinical tests described lack in sensitivity in mild gait impairment. To avoid that, it is 
possible to use specific movement analysis techniques that provide detailed quantification 
of walking. These techniques include body-worn inertial sensors, instrumented walkways 
and motion-capture systems, being able to detect differences in spatio-temporal gait 
parameters. This can lead to detect differences between persons with MS who have mild 
impairment and healthy controls. The early detection of gait changes could provide an 
early intervention (Sosnoff et al, 2011a). These advanced movement techniques allow the 
quantification of gait variability studying parameters like step time, step length or single 
support time. Some reports have shown a significant difference in gait variability between 
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persons with MS and healthy controls (Sosnoff et al, 2012). However, these procedures 
also have disadvantages: cost, need of laboratory space and processing data.  
 
A significant amount of research has been carried out in order to find a low cost, clinically 
feasible test that is also sensitive to mild impairment for early detection of gait disability.  
 
Functional scales  
This kind of scales should be sensitive and, therefore, change when the patient has a 
clinical course in either direction. They should not be subject to variation in different 
conditions, or carried out by different observers. They must be also easy to apply under 
different conditions, and useful in all phases of the disease. Ideally, they can be 
administered by non-specialists, which is also important to maintain a low cost 
(Weinshenke, 1996). 
 
Many clinical rating scales have been proposed to assess the impact of MS on patients, 
but only few have been evaluated formally for reliability, validity and responsiveness.  
 
In 1955, the DSS (Disability Severity Scale) was introduced by Kurtzke. The purpose was 
to create an objective approach to quantify the level of functioning that could be widely 
used by health care providers diagnosing MS.  The scale was modified several times to 
more accurately reflect the levels of disabilities clinically observed. The scale was 
renamed the Kurtzke Expanded Disability Status Scale (EDSS). The EDSS (Kurtzke, 
1983) was designed as an observing examination scored on an ordinal scale, and was the 
first one to be widely adopted as an outcome measure in MS (Pearson et al, 2004).  
 
The EDSS provides a total score on a scale that ranges from 0 to 10.  The first levels 1.0 
to 4.5, refer to people with a high degree of ambulatory ability, while the subsequent levels 
5.0 to 9.5, refer to the loss of ambulatory ability.  The range of main categories include (0) 
= normal neurologic exam; to (5) = ambulatory without aid or rest for 200 meters; disability 
severe enough to impair full daily activities; to (10) = death due to MS (Figure 4). In 
addition, it also provides eight subscale measurements called Functional System (FS) 
scores. These subscale categories are listed below.  The levels of function within each 
category refer to the eight functional systems affected by MS: pyramidal (motor functions), 
cerebellar, brainstem, sensory, bowel and bladder, visual, mental and other.  The total 
EDSS score is determined by two factors: gait and FS scores.  EDSS scores below 4.0 
are determined by the FS scores alone.  People with EDSS scores of 4.0 and above have 
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some degree of gait impairment.  Scores between 4.0 and 9.5 are determined by both gait 
abilities and the FS scores. 
(http://www.va.gov/MS/Professionals/Diagnosis/Kurtzke_Expanded_Disability_Status_Scale.asp) (15 
June 2014) 
 
The EDSS is widely used and accepted as a valid tool to clinically measure and evaluate 
MS patients’ level of functioning. The main problem of the EDSS scale is that it is ordinal. 
This scale cannot be used for parametric statistical comparisons, which disempowers the 
studies using this scale as a measure (Izquierdo and Ruiz-Peña, 2003). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Schematic representation of the Expanded Disability Status Scale. Taken from: 
http://mobilitymattersinms.ca/YourMobility/AssessmentTests (15 June 2014) 
 
1.2.3 Gait impairment in MS 
Gait dysfunction represents one of the most debilitating symptoms experienced by MS 
patients. 85% of individuals with MS report gait impairment as a major limitation of their 
lives. The majority of persons with walking difficulties also indicate activity restriction 
(80%), effects on emotional health (70%) and increased concern falling and other safety 
issues (70%) (LaRocca, 2011). 
 
Gait impairment in MS is believed to be multifactorial, linked to leg strength, spasticity, 
aerobic capacity and fatigue. There are increasing evidences that cognitive functions are 
also involved (Sandroff et al, 2013; Thoumie et al, 2005; Kelleher et al, 2010; Sosnoff et 
al, 2011b). It was proposed that an increase in gait variability results from an increase in 
fatigue in MS (Socie and Sosnoff, 2013).  
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Gait impairment is also important for indexing disease progression and rehabilitation in 
MS. The EDSS relies heavily on patient´s ability to walk. To date, the majority of research 
focusing on gait dysfunction in persons with MS has focused on clinical assessments 
(Gijbels et al, 2012) and average spatiotemporal parameters. Performance walking tests 
such as the timed 25-foot walk, 2-minute walk, and 6-minute walk are commonly used to 
measure gait function in MS and routinely demonstrate that persons with MS walk slower 
than healthy controls. Analysis of spatiotemporal parameters have revealed that 
individuals with MS walk slower, taking shorter, slower steps, and spending more of their 
gait cycle in double-support than healthy controls (Sosnoff et al 2011b). Deficits in gait 
have been observed in persons with MS compared to controls even at fixed walking 
speeds (Spain et al, 2012). Difference in performance was greatest in those with the 
highest amount of clinical disability (Goldman et al, 2008). 
 
At this moment the main rehabilitation options for gait impairment is pharmacological 
treatment of symptoms and physical rehabilitation. Pharmacological treatment target 
specific symptoms that have influence in gait. For instance, drugs that act to improve 
nerve conduction can improve walking speed in some cases but adverse side effects and 
cost are great disadvantages. On the other hand, exercise training can help to mitigate 
and restore some of the declines in walking function associated with the progression of 
disability in MS (Snook and Molt, 2009). 
 
Beyond the positive effect of exercise on walking function shown in general for a range of 
disability levels in MS, research using advanced motion techniques gave evidences that 
there are changes in kinematics of gait even in the absence of clinical disability in patients 
of MS. These early gait changes reveal the importance of understanding the possible 
beneficial effect of gait therapies in persons with MS showing minimal walking impairment 
(Martin et al, 2006). 
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1.3 Traditional Chinese Medicine (TCM) 
 
1.3.1 Overview of TCM 
From the earliest times man tried to fight against disease and pain. One of the oldest 
therapeutic systems used by mankind for health and wellbeing is the Traditional Chinese 
Medicine (TCM). The origin of Traditional Chinese Medicine is uncertain but 
archaeological findings indicate that it has more than 5000 years. There have been found 
therapeutic instruments used between 4000 and 6000 years ago (Hempen and Chow, 
2006). At these early times not only stone needles, but also bamboo splinters, were used. 
Later, metal medical needles made of bronze, iron, gold, and silver began to be used.  
 
Over the centuries there is abundant literature related to the general practice of TCM. The 
oldest medical manual “Huangdi Neijing” (The Yellow Emperor´s Inner Classic) was 
written more than 2300 years ago. In this book it was established therapeutic treatment for 
the first time in the practice of Chinese Medicine. The first classical work “Zhenjiu Jiayi 
Jing” (The Systematic Classic of Acupuncture and Moxibustion) by Huang-Fu Mi, dates 
from 215-218 AC, and provides, for the first time, a clear terminology, a careful topological 
description of individual acupuncture points and a systematic indication of their effects 
(Hempen and Chow, 2006). The first official TCM school, the Imperial Medical School (Tai 
Yi Shu), was founded in China in 624 AC. In the following centuries several textbooks 
were produced and had great importance to spread knowledge at that time. Later, in 
1601, “Zhenjiu Dacheng” (Great Compendium of Acupuncture and Moxibustion) was 
published by Yang Jizhou in which the theory underlying the whole of Chinese Medicine 
was presented. For the past 50 years, several hundreds of textbooks and monographs on 
TCM have been published. According to the WHO, today, a sophisticated body of 
knowledge was built over centuries, including basic theory, diagnostic procedures and 
treatment approaches that are now available (WHO, 1996). 
 
From the third century to the end of the nineteenth century new developments took place 
in TCM, for instance, the number of acupuncture points used for treating various diseases 
greatly increased. Since the establishment of the People’s Republic of China, policies for 
TCM were implemented in China (Xia et al, 2010). Nowadays, higher education is 
available in a substantial number of TCM universities, medical universities and faculties all 
over the world (Santos, 2012). 
 
TCM doctors soon perceived that the human being is a living being integrated in an 
environment that influences him. Thus, concepts used to explain nature, such as Yin/Yang 
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and Five Elements, became central to TCM theory. The goal of the clinician in TCM is to 
maintain the body in a harmonious balance, both internally and in relation to the external 
environment (Santos, 2012). To reach this aim, TCM can use different tools including: 
Chinese pharmacology (phytotherapy), Qigong (biofeedback neurovegetative exercises), 
dietetics, Chinese manual therapy (Tuina), and acupuncture.  
 
The concept of Yin-Yang is the basic concept of all the oriental sciences. It matches the 
precondition for the origin of all natural phenomena. The ancient Chinese civilization 
realized that opposites are not belonging to different categories, but rather two sides of 
the same reality. There is a dynamic equilibrium in which opposites are interdependent, 
which means that reality is seen as a manifestation of the interplay between opposites. 
These opposites are called Yin and Yang. Yin and Yang are the expression of duality, and 
the strength matrix of a cyclic motion interpolation (Cerqueira, 2004). The Yin-Yang 
balance is primordial in all vital processes of adaptation of the living beings and their 
environment (Nguyen, 2011). 
 
As ancient Chinese doctors went through the understanding about the material world, the 
Theory of the five elements was formed, describing the characteristics of these elements 
and their relationships, including their activities and changes. The Theory of the five 
elements holds that nature is constituted by five substances: wood, fire, earth, metal and 
water. The development and changes in anything or phenomenon are the results of 
continuous movement, intergeneration, and inter-inhibition (inter-dominance) of these five 
elements. In Traditional Chinese Medicine, this theory applies mainly to explain the 
pathophysiological features of all internal organs and tissues of the human body, 
pathophysiological relationships between them and the relationship between human body 
and the changing environment, in order to provide guidance in diagnosis and treatment 
(Ping, 2002). 
 
Ancient Chinese doctors linked in a logic way the physiology and pathology of the Zang-
Fu (viscera and organs) and tissues of the human body with environmental factors that 
has to do with life of humanity. Organs and body tissues are classified into five categories, 
taking the five elements as a base, and according to their different properties, functions 
and shapes, in order to use as a reference for observing internal relationships and their 
movements (Ping, 2002). 
 
According to TCM theories, diseases were cured mainly by means of adjusting the 
relationship between Yin and Yang, promoting the communication between the channels 
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and collaterals (conduits), regulating the vital energy (Qi) and blood (Xue), reinforcing 
positive factors, and eliminating negative ones (Agents) (Xia et al, 2010). 
 
1.3.2 The Heidelberg Model of TCM 
The Heidelberg Model of TCM was developed by Prof. Johannes Greten supported by the 
pioneering works of the medical-sinologist Prof. Manfred Porket, thus adopting a Latin 
terminology, and by the Leibniz’ analysis of the I Ging (“The Book of Changes”). In this 
model, the central postulates of Chinese Medicine are recompiled and explained as a 
logical model of system biology, based on a mathematical language (Greten, 2007). This 
model unifies the contemporary medical-scientific knowledge with the concepts of different 
schools of Chinese medicine. It sees Chinese medicine as a novel vegetative medicine. 
Greten (2010) defined TCM as “a system of sensations and findings designed to establish 
a functional vegetative state”. 
 
Important concepts 
Chinese medicine is based mainly on a system that describes functional abnormalities by 
the sensations (signs and symptoms) felt in a specific way by the patient, and these 
symptoms come from specific dysfunctions. In a state of health, there is a harmonious 
balance between Yin (structure, substance) and Yang (function), a balance between 
ascending and descending vectors of human regulation (homeostasis). In this context, 
Yang represents the driving force for activities and warmth. Yin represents deep rest, cold, 
dampness and nourishing the tissue. We can find such paired Yin-Yang, at different levels 
in human body: Kinases (Yang) and phosphatases (Yin); the pro-oxidants and 
antioxidants in lipoproteins, to give some examples (Santos, 2012). 
 
One of the fundamental concepts in TCM is Qi, usually translated by energy, vital force or 
vital energy. It is the foundation of everything and the immaterial force that promotes the 
activity of the organisms. According to the Heidelberg model of TCM Qi is defined as 
“vegetative functional capacity of tissues and organs that can cause a sensation of 
pressure, tearing or flow” (Greten 2010).  When Qi is strong and balanced, there is health, 
if it is weak, or move in the wrong direction, there is pathology. Thus, the correct 
movement of Qi is the base for the movement of Xue, for transformation of Jing, the 
correct movement of body fluids, digestion and adsorption of food, hydration of the 
organism and resistance to pathogenic factors.  
 
According to Heidelberg model of TCM we can define Xue and Jing as follows: 
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 Xue refers to a “form of functional capacity bound to body fluids with functions 
such as warming, moisturizing, creating Qi and nitrifying a tissue”. From a western point of 
view the clinical effects of Xue can be compared to the effect of microcirculation, including 
blood cells, plasmatic factors, endothelium and parenchyma.  
 Jing refers to the “structure potential that includes the functional repertoire of a cell 
via the DNA and at the same time reproductive functions”.  
 
In TCM, understanding the concept of Shen (that can be compared to certain higher brain 
functions in western medicine) is also fundamental. Greten (2010) define Shen as 
“functional capacity to put order into mental associativity and emotions, thus creating 
mental presence”. The functional state of Shen is evaluated by signs as the coherence of 
speech, the gloss of eyes and fluent fine motoric (control of motor functions). 
 
Phases and orbs 
In the scientific approach of the Heidelberg model of TCM, phase is a central concept. 
“Phase is a regulatory term, part of a circular process that, when referring to men, 
expresses a vegetative functional tendency, and which manifestation is defined as an orb” 
(Greten 2010). There are five phases: wood, fire, earth, metal, water. To each phase 
corresponds a vector. The phases present a cyclic pattern that can be represented as a 
sinusoid curve around of target-values (Figure 5). Each phase is represented by two orbs, 
one with Yin characteristics and another with Yang, with the exception of the Fire phase 
that has four orbs (Greten 2010). In total there are twelve orbs: Hepatic, Felleal, Cardiac, 
Tenuintestinal, Pericardial, Tricaloric, Stomach, Lienal, Pulmonary, Crassintestinal, Renal 
and Vesical. 
 
According to cybernetics (regulatory processes), periodic fluctuations of regulation 
happens around a target value, activating or de-activating mechanisms responsible for 
body transformations. This regulation process is expressed at different vegetative 
functional states and follows a sinusoidal curve (Seca, 2011). As can be seen in the 
Figure 5, Yang phases (wood and fire) are regulated mainly by sympathetic system, while 
in Yin phases (metal and water) parasympathetic activity is predominant. 
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Figure 5: Phases Wood, Fire, Metal, Water according to the functional  
vegetative state of the organism and its manifestations. Taken from Greten (2010).  
 
Our body is continuously exposed to daily interactions with the environment. But 
sometimes the vegetative tendency becomes more intense and then manifestations of this 
tendency appear. When this happens, the continuum of regulation is disrupted and 
pathological manifestation happen. Thus, there are two functional states: the continuum, 
in which the functional manifestations of vegetative tendency disappear during the 
homeostatic process, and the state of dominance of a signal which becomes a critical 
symptom (Greten, 2010). 
 
Mechanisms of pathogenesis 
According to the Heidelberg model of TCM, there are four principal mechanisms of 
pathogenesis: 
 
 Deficient transition - The vegetative tendencies, the phases, should be clearly 
transformed one into another, so that the equilibrium remains constant. Occasionally, 
there is a lack of functional capacity of transformation in the body. The power of 
transformation of a vector into another, within the circular function, is blocked, stopping 
the cycle of regulation and resulting in pathological signs (Santos, 2012) 
 Imbalance agonist/antagonist - When there is an imbalance of agonists or agonists 
and antagonists, one of the phases will be in excess, leading to signals of the phase in 
excess (Greten, 2010). 
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 Excess of an agent – If an agent is continuously present, the phase with which it is 
related is also continuously produced, leading to an increase of the respective vector. 
(Seca, 2011) 
 Yin deficiency - The regulation model of the body can be compared to a 
thermodynamic system. Thus, when a structure with less matter is subject to variations it 
will manifest a more unstable variation curve, leading to higher peaks of the variable, 
nevertheless, the turning point will be achieved faster. In terms of TCM, lack of Yin means 
lack of substance (matter) this is why Yin deficiency causes an extreme course of the 
curve of regulation. It leads to labile Qi.  
There are four types of yin deficiency: lack of functional tissue (yin deficiency "sui 
generis"); lack of body fluids; lack of microcirculation within the tissue (lack of Xue); 
functional deficits at the cellular level (lack of Jing) (Greten, 2010) 
 
Diagnostic 
The differential diagnostic in TCM results from the collection of relevant data gathered by 
different tools of evaluation of the patient:  
1-Observation of the body shape, of parts of the body (skin, face, lips, tongue and 
mucosa), actions and movements, tone of voice, caught, breathing and smell. 
2-Querying about: clinical history, pass disturbances, habits, food habits and appetite, 
temperature sensation, type and location of pain. 
3-Palpation of skin, members, hands, thorax, abdomen and acupoints. 
 
The Heidelberg model shows that TCM diagnosis can be regarded as the vegetative state 
of the body, which can be defined by key symptoms. Thus, to establish a TCM diagnostic 
four steps are necessary (Figure 6):  
1-The first step will be the analysis of patient´s constitution. From the constitution the 
patient's inner nature can be verified, that means his/her tendency of action-reaction, 
based on his/her phenotype and in his/her body language/communication.  
2-The second step will be to investigate the agent involved in the pathogenic process. An 
agent or pathogenic factor is regarded as a functional power that causes changes in the 
functional properties of the individual and produces its own clinical signs, inducing 
diagnostic relevant signs (orbs). The agent can be classified as external, (ventus, algor, 
ariditas, aestus, ardor), internal (ira, voluptas, maeror, timor, pavor, solicitude, cogitacio) 
and neutral (bad nutrition, accidents, among others).  
3-The affected orb will indicate the functional state of a body region, which correlates with 
the functional properties of a conduit (Greten 2010). 
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Figure 6: Schematic representation of the components of functional diagnosis in TCM according to 
Heidelberg model. Taken from Greten (2010). 
4-The fourth step will be to analyse the four guiding criteria. These guiding criteria are an 
interpretative approach of body regulation, according to the Heidelberg Model of TCM. 
The body regulation is observed at four different levels:  
 Neurovegetative level (repletion/depletion). In general, signs of repletion indicate 
too much Qi, an excess of vegetative stimulation. Signs of depletion indicate lack of Qi, a 
lack of activation, an excess of de-activation; 
 Humorovegetative level (Calor/Algor). Calor means over activation of Xue 
(microcirculation) and algor means lack of signs of functional microcirculation;  
 Neuroimmunlogical level (exterior/interior). Evaluates the level of achievement of 
the effects of an exterior agent when it invades the body. The most common 
pathophysiological model underlying this mechanism is the model of six stages of Zhang 
Zhongjing, called Shang Han Lun (“Algor Leading Theory” or ALT). 
 Structural, cellular level (Yin/Yang). This criterion allows distinguishing whether the 
symptoms/signs correspond to a primary dysregulation, a functional dysregulation (Yang) 
or if these symptoms represent a secondary dysregulation, a structural deficit, a deficit in 
functional tissue (Yin). 
 
The ALT model (Figure 7) referred before is based on the idea that the agent invades 
from the exterior to the interior (from the extima to intima), thereby overcoming the 
defence levels, affecting the flow of Qi and Xue. It constitutes a specific approach of 
interpretation of the 3rd guiding-criteria: extima/intima, as stages I to III are extima (Yang) 
and stages IV to VI are intima (Yin).  
 
Effects of Acupuncture on Gait of Patients with Multiple Sclerosis 
 
 56 
 
 When the external agent algor (cold) invades the skin, the first defensive layer is 
affected: the defensive Qi, and may induce a localised de-activation of Xue, in western 
terms, a regional lack of microcirculation. As the body is unable to warm that specific 
region, it reacts producing reactive calor to warm the conduits and extima in order to expel 
the invading agent. Thus, algor may affect primarily the conduits that contain more Xue 
than Qi: the Vesical and Tenuintestinal conduits - ALT Stage I (Yang major) 
 If this attempt to expel algor fails, the agent continues the invasion. The flow of Qi 
is blocked more easily than of Xue, as “Qi moves the Xue”, so the phases and orbs more 
prone to this affection are the ones more dependent on Qi, Stomach and CrassIntestinal. 
The production of reactive calor reaches the highest point (Spendor Yang) - ALT Stage II.  
 If the agent continues the invasion, it overcomes the flow of Xue within the 
conduits, it may lead to a reverse flow of Xue into the interior, with a relative lack of 
reactive heat. Frequently, Xue from the inside will be mobilized against the agent causing 
sensation of internal heat. It may be said that the agent algor and the flow of Xue within 
the conduit drives each other in and out repeatedly - ALT Stage III (Yang Minor). As this 
stage occurs still on the extima, and the mobilization of internal heat is a feature of the 
phase wood, it affects the Felleal and Tricaloric conduits, as there are symptoms and 
signs of “imbalanced distribution” of energies.  
 On the Stage IV (Yin major), the calor is overwhelmed and the algor invades the 
interior: the guiding-criteria algor is present. When algor affects the Qi of the body islands, 
the orbs affected are those more sensitive to diminished activity of Qi, the Lienal and 
Pulmonary orbs. 
 When algor affects the Xue of the body island, orb functions depending on Xue are 
more easily affected, the Hepatic and Pericardial orbs - Stage V (Yin flectens). When 
algor affect the body island Xue, it represents the lowest point of energy in which reactivity 
has totally vanished, and is called the “flat-down” phase, a breakdown of orthopathy. 
Stage V is decisive for the survival of the individual. 
  If Yin and Xue are still available, then is possible to warm up slowly towards Stage 
VI (Yin minor). In Stage VI the hypofunctional Yin state has an upward direction 
comparable to the phase of water (regeneration) in the model of phases, having the 
capacity to regenerate. At this stage Cardiac and Renal orbs are involved. 
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Figure 7: The ALT model. Taken from Greten (2010) 
 
 
1.3.3 Acupuncture 
Acupuncture is an important component procedure in TCM which prevents and treats a 
disease by puncturing certain points of the body with needles. Traditionally, acupoints are 
defined as the sites through which the Qi and Zang-fu organs (horreales-aulici in the 
Heidelberg model) are transported to the body surface (Lu et al, 1990). Much of the theory 
accepted today was first recorded in the Middle and Late Zhou dynasties. The recorded 
history of acupuncture starts from about 1520 BC and comes nearly to an end in 1911. It 
is useful to remind this long history and vast wealth of empirical evidence of acupuncture 
(Hopwood and Donnellan, 2010). 
 
The Consensus Development Conference (CDC) on Acupuncture held by the National 
Institute of Health (NIH) in 1998 evaluated the scientific and medical data on the uses, 
risks, and benefits of acupuncture procedures for a variety of conditions. The statement of 
CDC on Acupuncture suggested that acupuncture is effective for several diseases and 
that further research is likely to uncover additional areas where acupuncture interventions 
will be useful. Also, it is important to point out that according to several authors, one of the 
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advantages of acupuncture is that the occurrence of adverse side effects is very low (Xia 
et al, 2010). 
 
Also the WHO (2002) has issued statements confirming the usefulness of acupuncture in 
the treatment of a wide variety of conditions. Currently, the practice of acupuncture is 
spread over 160 countries and regions. According to the World Health Organization the 
diseases or disorders for which acupuncture therapy has been tested in controlled clinical 
trials reported in the literature can be classified into four categories as shown below 
(Table 1) 
 
Table 1: Classification of diseases according to acupuncture clinical trials of literature 
 
 
Several studies in neurophysiology concluded that acupuncture has the main function to 
mediate the body homeostasis, acting mainly in the balance of autonomic, neurochemical 
and humoral functions. Findings from basic research have begun to elucidate the 
mechanisms of action of acupuncture (NIH, 1998). It is now accepted that three general 
mechanisms can explain this action: energetic, neural and humoral mechanisms (Figure 
8). 
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Figure 8: Proposed mechanisms of action of acupuncture. 1-Energetic, 2-Neural, 3-Humoral 
mechanisms 
 
1-Energetic mechanism: 
A growing number of scientists see the TCM as a cybernetic (regulatory) model. In terms 
of cybernetic, the conduits (sometimes also called meridians) are information pathways 
that connect the whole body: upper with lower parts, left with right, interior with exterior 
and all of them together. The conduits would represent the relationship among various 
parts of the body. We know now that the human body has multiple levels of neural 
networks that transmit information of different kinds. When an organ, tissue or system 
becomes imbalanced, information of these disorders are transmitted through specific 
areas of the body. These areas are reflex points (acupoint) or information zones. To the 
physiologist Guan Yuan, an acupoint is actually the location on the body surface 
outputting internal information and inputting treatment information from acupuncture 
(Guan-Yuan, 2006; Porket and Hempen, 1995). 
 
Several studies reveal also a relationship between the conduits and the nervous system, 
blood vessels and lymphatic vessels. The morphological observation of 324 acupoints 
revealed that 323 have innervation of cranial and spinal nerves; 304 are related to 
superficial cutaneous nerves, 155 with deeper nerves and 137 with deeper and superficial 
nerves. Similarly, the acupuncture points and the nerves of its correlated organs belong to 
the same spinal segment or to the interior of the same nerves segment to which the organ 
belongs (Guan-Yuan, 2006). 
 
With respect to blood vessels, among 309 points, 24 are on top of an artery, while 262 are 
adjacent to an artery. Besides, from the location of acupuncture points we can see that 
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the conduits are closely associated with blood vessels. The arterial vascularization in the 
area of acupuncture points has certain ways - regular convergences, irradiation or less 
regular arrangements. For those who have regular arrangements, the points are located 
frequently in the centre of such arrangements. (Qiu Mao, 2001). 
 
Some research has found that the conduits are also related to lymphatic plexus or to 
lymphatics vessels and lymph nodes. Pulmonal, Stomach, Cardiac and Lienal conduits, 
are found almost entirely in vascularization of lymphatic vessels, adapting deeply or 
superficially to their corresponding distribution (Qui Mao, 2001). 
 
2-Neural mechanism 
Through various neural reflexes such as axonal reflex and spinal reflex, acupuncture can 
result in instant regulatory effects on functions of corresponding organs and tissues. For 
instance, the excretion of bladder, movement of the rectum and instant contraction of 
blood vessels and other reactions could be induced in this way (Guan-Yuan, 2006). 
 
3-Humoral mechanism 
It refers to the production of substances that are secreted into the blood through the action 
of acupuncture, like hormones. This mechanism can be further divided into two ways. The 
first is that acupuncture acts on related organs directly through effects on factors 
secretion. The second is that acupuncture acts on target organs through the feedback 
control of secretion. These factors include endogenous opiate-like substances and many 
neurotransmitters such as: serotonine, acetylcholine, non-epinephrine, dopamine, among 
others; and include hormones like prolactin, growth hormone (GH), thyroid-stimulating 
hormone, (TSH) and cortisol. Among the humoral factors, endorphins or enkephalins, are 
the most significant (Guan-Yuan, 2006; Santos, 2012). 
 
Neural and humoral mechanisms are associated during regulatory process of 
acupuncture. Sometimes neural factors are primary to humoral factors, but sometimes it is 
in the other way round. 
 
The increasing importance of acupuncture in recent years as a form of therapy, and the 
interest of introducing it into primary health care, requires that national health authorities 
must ensure safety and competence in its use. This means that training in acupuncture 
should be extended at college level, and suitable mechanisms for supervision of its 
practitioners have to be created (WHO, 2010). 
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1.3.4 Multiple sclerosis according to TCM 
The most commonly adopted TCM staging for MS was originated by British acupuncturists 
Blackwell and MacPherson (1993) and offers a logical framework for treatment.  
 
According to Traditional Chinese Medicine, MS can be considered as four stages 
(Hopwood and Donnellan, 2010):  
 The first stage is remission, either before the disease process has really started or, 
far more likely, as an interval where symptoms recede and a near normal state is 
regained. 
 
 In the second stage conduit symptoms predominate and the patient aware of 
sensory or minor motor changes. This indicates a progression of the disease and the 
symptoms may now include numbness in the lower limbs with accompanying weakness, 
slackness of joints and gravitational oedema. The whole body feels heavy and the legs 
may feel cold. The joints are often painful. The patient does not react well to heat. 
Occasionally there is fever. The tongue is greasy with a yellow coat and the pulse is rapid 
and slippery. As the disease progresses, evidence of Zang Fu organ failure becomes 
apparent, with the patient now feeling fatigued and often ill. Chinese theory holds that MS 
is fundamentally an invasion of external agent: “Damp Heat” (Calor and Humor), possibly 
originally caused by an invasion of “Cold Damp” (Algor and Humor) and this will begin to 
affect the Stomach, Lienal and Hepatic. 
 
 In TCM terms, in the third stage, the production of Qi and Xue by the Lienal is 
diminishing, resulting in deficiency. The retention of “Damp” (Humor) in the system 
weakens the Lienal further, initiating a vicious circle. The symptoms include tiredness, 
listlessness, flaccidity of muscles and a tendency to fatigue. The patient may have a poor 
appetite and suffer from bowel problems, in particular loose stools. Blurred vision, always 
worse when tired, and a pale dull face are also found. There may be muscle stiffness with 
cramps, spasticity and mild tremor. 
 
 In fourth stage the problem predominantly is Kidney (Yin and Yang) deficiency. 
Symptoms include severe weakness and fatigue. The patient often appears spiritless and 
there may be a pale complexion and premature ageing. Muscle weakness and atrophy 
are likely to be marked. Stiffness and muscle spasm are also common with severe tremor 
and ataxia. Low back pain is often very distressing. Other symptoms are urinary urgency, 
incontinence or retention.  
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1.3.5 Heidelberg model of TCM and Multiple sclerosis 
The paraorb of the brain (paraorbis cerebri) refers to signs and symptoms that are related 
to general functions associated with the brain. It is a paraorb because is considered to be 
a semi-autonomous group of signs, within the general understanding of the Renal orb. 
That means that signs of the paraorb (loss of memory, loss of speed of mind and velocity 
of thinking) occur in the phase Water (Renal orb). 
 
In the system of the phases, neurological functions are also related to the Cardial orb 
(phase Fire), as this is the counterpart of the Renal orb. The neurological term referring to 
Cardial function is Shen (the ability and the power to create coherence of perception, 
coherence of speech, fluent fine motorics) (Table 2) 
 
Table 2: Correspondence between terms in Heidelberg model of TCM and  
conventional medicine terms 
 
TCM (Heidelberg model) Western terms 
Renal orb (paraorbis cerebri) Higher nervous functions 
Cardial orb Fluent fine regulation 
 
If the Renal orb is not counterbalanced by the Cardial orb, then signs of phase Wood can 
appear (muscular spasticity, for instance). In general, these neurological symptoms are, 
according to TCM, ventus internus. At the same time Yang deficiency appears and causes 
lack of upward movement. In the system of the phases, Hepatic and Lienal vectors are 
affected, resulting in symptoms like lack of muscular power, lack of Xue within the limbs 
with flaccid palsy. This lack of Xue can also be related with the model of the six stages 
(ALT), explained previously. 
 
According to the Heidelberg model of TCM the attack of the agent algor leads to 
production of reactive calor that has as a consequence a Splendor Yang syndrome (Stage 
II of the ALT), with accumulation of pituita (humor+calor). If this feature chronifies, can 
results in a Stage VI (Yang minor) with the Cardial (weak cardial Yin) and Renal orbs 
(paraorbis cerebri) involved. The Renal orb may produce a tendency to ventus internus. 
Frequently, a chronic Splendor Yang proceeds into a Yin minor syndrome (Stage VI of 
ALT) with expression of Cardiac and Renal symptoms. The presence of labile Qi makes 
also to appears signs of Stage I of ALT (Yang major). 
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In summary, according to Greten (2010), MS shows lack of fluids, Yin and Yang 
deficiency and labile Qi (Figure 9). 
 
 Figure 9: MS according to Heidelberg model of TCM. Adapted from Greten (2010). 
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2. CLINICAL RESEARCH PROTOCOL 
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2.1 Aim of the study 
The main objective of the study is to evaluate the effect of a specific acupuncture protocol, 
according to Heidelberg model of TCM, in the gait impairment in patients with Relapse-
Remitting Multiple Sclerosis (RRMS). 
 
2.2 Sampling and Recruitment Procedures 
This study had the collaboration of the two associations of patients with MS with facilities 
in Oporto region: the "National Association for Multiple Sclerosis" (ANEM) and the 
"Portuguese Multiple Sclerosis Society" (SPEM). In both associations previous meetings 
were held to explain the objectives and the study design and the directors of both 
institutions showed their willingness to collaborate in the study (Annex 1). In addition, the 
study had the approval of the ethics commission of the Institute of Biomedical Sciences 
Abel Salazar (ICBAS) (Annex 2).  
 
Prior to the development of the study, a free workshop was held in the SPEM            
(Annex 3) where aspects related to the objectives and design of the study, as well as the 
possible adverse effects of the treatment with acupuncture, was addressed. Doubts of 
patients regarding acupuncture treatment and, in general, to Traditional Chinese Medicine 
were also clarified. After this seminar, and before developing the study, patients who 
voluntarily showed their willingness to participate, signed the corresponding informed 
consent (Annex 4). 
 
The criteria for inclusion/exclusion of the patients in the study are shown in Table 3 
. 
 Table 3: Inclusion/exclusion criteria in the study 
Inclusion criteria Exclusion criteria 
Patients with diagnosis of MS of 
Relapse-Remitting type. 
Patients with diagnosis of other 
pathologies. 
18-70 years of age. Patients with psychiatric diseases. 
 
Stable symptoms in last two months. Patients with severe cognitive 
deficiencies. 
EDSS (Expanded Disability Status 
Scale) between 3 and 7. 
EDSS (Expanded Disability Status 
Scale) higher than 7. 
 
After applying the inclusion/exclusion criteria, 20 patients were selected (Figure 10). 
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Figure 10: Schematic representation of the selection process 
 
2.3 Prospective randomized clinical study  
Initially, clinical and personal data of each patient were collected. Then, gait was 
evaluated in all patients. This evaluation was performed by the 25-foot walk test (T25FW), 
a timed walking over a fixed distance measure, which has been extensively used to 
evaluate gait problems in neurological conditions and MS. The following instructions were 
given to patients for the completion of the test: “walk, as fast and safety as you can, 
across a clear marked linear 25 feet course. There are no turns, start is static and 
assistive device can be used” (Figure 11). After that, the same test was done but in a 
tandem walking way. Tandem gait is a method of walking (or running) where the toes of the 
back foot touch the heel of the front foot at each step (Figure 11). Neurologists sometimes 
ask patients to walk in a straight line using tandem gait as a test for unsteady gait to bring 
out abnormalities in gait and balance. Some disorders can cause unsteady gait, such as 
vision difficulties and problems with the motor neurons or associative cortex. 
 
   
Figure 11: 25-Foot Walk Test (left); Tandem walking test (right) 
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In addition to these tests, it was asked to all patients to complete the survey Multiple 
Sclerosis Walking Scale 12 (MSWS12). This survey consists of 12 questions that assess 
gait impairment in terms of the speed, distance and daily activities impact perceived by 
the patient. The MSWS-12 has been validated as a measure of walking function and as 
responsive to gait changes. The survey used in this study had been validated for 
Portuguese language (Nogueira et al, 2012) (Annex 5). 
 
Patients were then randomized into one of two groups (A and B). The intervention was 
divided into two moments. In a first moment, A group patients received a “true 
acupuncture treatment”, according to Heidelberg model, and patients of group B received 
“sham acupuncture treatment” (treatment using points not considered as the best 
according to Heidelberg model). All patients of the study were blinded to randomization 
assignments. Before and after each treatment, gait impairment evaluation was performed.  
 
The second moment of intervention happened at least two weeks later. This time, group A 
of patients received “sham acupuncture” and group B “true acupuncture”. Before and after 
each treatment, gait impairment evaluation was performed (Figure 12). 
 
 
Figure 12: Schematic representation of the intervention process 
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Acupuncture protocol  
Acupuncture treatments were administered only by one acupuncturist (the researcher). 
For the study, a standardized acupuncture protocol was developed, based on Heidelberg 
Model of TCM. True acupuncture was done using acupuncture points, anatomically 
located in the lower extremities: S34 (ST34), V40 (BL40), V57 (BL57) (Figure 13) (Greten, 
2012) 
 
 V40 (Bl40): Point activating the whole vesical conduit. It is useful in humor 
blockades leading to stiffness in the course of the vesical conduit. As a conjuntory, it is 
important for Yin deficiency. It also has an effect for ventus internus and spasm. It 
strengthens the loins and the knees. 
 V57 (Bl57): Important point if there is pain when walking. It enhances upward 
movement of the renal orb. It is also good for Reno-Lienal syndrome (a mild and chronic 
Yang deficiency). It has an effect in paralysis of lower extremities and tense muscles. 
 S34 (ST34): Point that increase Qi flow. It dispels damp-cold (humor-algor). It is 
important in numbness and weakness and for pain in the knee and leg.  
 
Sham acupuncture was done using points located 2 cun laterally to the ulnar border of the 
leg, out of any conduit. 
 
Acupuncture technique called “Leopard spot technique” was used in the study. In this 
technique some drops of blood let out from peripheral points by quickly stabbing the skin 
(five or six times) with the needle (Chen et al, 2001; Saghaei and Razavi S, 2001). For 
this technique, sterile disposable needles with a size of 30G, 0,30x8mm were used  (BD 
Micro-Fine®).  This acupuncture technique is used to increase the flow of Qi and Xue and 
to disperse blood stasis.  
 
Each session of acupuncture lasted approximately 20 minutes.  
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Figure 13: Anatomic localization of the acupuncture points used in the study according to 
Heidelberg model of TCM (“true acupuncture”) Taken from Greten (2012) 
 
2.4 Statistical analysis 
For the execution of this work two softwares were used:  
-Microsoft Excel® 2010. The use of this program gives advantages in the interpretation, 
organization and exploratory data analysis, particularly in relation to the descriptive 
statistics. 
 
-SPSS (Statistical Package for Social Sciences)® Statistics 20 was used for comparisons. 
Nonparametric Wilcoxon for paired samples test was used to assess between-group 
comparisons as unadjusted analyses. Nonparametric tests had to be used because of the 
lack of normality distribution of data. All p-values below 0.05 were considered statistically 
significant. 
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3. RESULTS  
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3.1 Sample characterization 
The study sample consisted of 20 individuals. All of them were recruited from the two 
associations of patients with MS that are operating in Oporto region, ANEM and SPEM, as 
mentioned in the previous chapter. All the individuals had the diagnosis of multiple 
sclerosis of relapse-remitting type (RRMS), without any relapse in the previous two 
months. The collection of data was done during the months of June and July of 2014. 
Each patient was identified with a reference number. Socio-demographic and clinical 
characterizations of the 20 individuals of the sample are shown in Table 4. 
 
Table 4: Socio-demographic and clinical characterization of the sample 
 
Identification 
nº 
Sex 
* Age 
Time from 
diagnosis 
(years) 
Age at 
diagnosis 
Date of last 
relapse 
Main 
complain 
Medication 
** 
Assistive 
Devices 
*** 
01/ F 45 1 44 2013 Tiredness Copaxone N 
03/ M 50 8 42 Before 2013 Disbalance Rebif N 
04/ F 49 15 34 Before 2013 Fatigue Without medication N 
05/ M 27 4 23 2013 Fatigue Natalizumab N 
06/ M 54 24 30 1990 loss memory Copaxone N 
07/ F 58 14 44 2000 Disbalance ? Y 
08/ M 28 6 22 2011 Tiredness Lepicortinolo N 
09/ M 25 6 21 2010 Fatigue Rebif N 
10/ F 50 6 44 2008 Disbalance Rebif N 
11/ F 46 28 18 01/2014 Disbalance Copaxone N 
13/ F 50 25 25 Before 2013 Disbalance ? Y 
14/ F 49 3 46 2011 Tiredness Rebif N 
15/ F 61 2 59 2012 Tiredness Rebif Y 
16/ F 48 6 42 02/2014 Tyreness Interferon B Y 
17/ F 37 14 23 2013 Tiredness Fingolimod Y 
18/ F 52 7 45 2013 Tiredness Natalizumab N 
20/ M 33 10 23 2004 Spasm Without medication N 
21/ F 66 9 57 2005 Disbalance Interferon B N 
22/ M 49 24 25 2010 Disbalance Copaxone N 
23/ M 48 15 33 02/2014 Tiredness Rebif N 
*F: Female; M: Male; ** ?: the patient doesn´t know the medication; ***N: No; Y: Yes 
 
As we can see in Table 4, from the 20 patients, 12 were females (60%) and 8 males 
(40%) (see also Figure14). These results correspond to a female-male ratio of 1.5. 
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Figure 14: Distribution of the sample according to gender  
 
With respect to quantitative variables, namely, age, time from diagnosis and age at 
diagnosis, Tables 5, 6 and 7 summarize the descriptive analysis, when considering the 
whole sample (n=20) (Table 5) and considering females (n=12) (Table 6) and males (n=8) 
(Table 7) separately. 
 
Table 5: Descriptive analysis of age, time from diagnosis and the age at diagnosis when 
considered all individuals of the sample (n=20) 
 
 
 
 
 
 
 
 
Table 6: Descriptive analysis of age, the time from diagnosis and the age at diagnosis for females 
in the sample (n=12) 
 
N=12 Age Time from diagnosis Age at diagnosis 
Mean 50,9 10,8 40.1 
Median 49,5 8,0 44 
Maximum 66,0 28,0 59 
Minimum 37,0 1,0 18 
Standard deviation 7,69 8,71  
 
 
 
 
 
  
N=20 Age Time from diagnosis Age at diagnosis 
Mean 46,3 11,4 35 
Median 49,0 8,5 33.5 
Maximum 66,0 28,0 59 
Minimum 25,0 1,0 18 
Standard deviation 11,07 8,25 12,44 
Effects of Acupuncture on Gait of Patients with Multiple Sclerosis 
 
 77 
 
Table 7: Descriptive analysis of age, the time from diagnosis and the age at diagnosis for males in 
the sample (n=8) 
 
N=8 Age Time from diagnosis Age at diagnosis 
Mean 39,3 12,1 27.4 
Median 40,5 9,0 24 
Maximum 54,0 24,0 42 
Minimum 25,0 4,0 21 
Standard deviation 12,09 8,04  
 
According to our data, both, the mean age and the mean age at diagnostic were lower in 
males than in females.  
 
Figure 15, Figure 16 and Figure 17 present the frequency distribution of the qualitative 
variables described in Table 4, namely, main complain, medication and the use of 
assistive devices, considering female and male patients separately.  
 
 
Figure 15: Frequency distribution (%) of the main complain of the patients 
 
 
Figure 16: Frequency distribution (%) of the medication used 
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Figure 17: Frequency distribution (%) of the use of assistive devices 
 
3.2 Gait assessment before and after acupuncture treatment (25-Foot Walk test) 
Results of the 25-Foot Walk test (T25FW) were measured in seconds. Table 8 shows the 
results obtained before and after each true acupuncture and sham acupuncture treatment. 
The corresponding percentage of improvement experienced by each patient is also shown 
for each treatment. 
 
Table 8: Results of the 25-Foot Walk test before and after true and sham acupuncture 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
25%
35%
0%
40%
0 2 4 6 8 10
Assistive Devices
No assistive devices
Male
Female
 True acupuncture Sham acupuncture 
Identification 
nº 
T25FW-
before 
(seconds) 
T25FW-after 
(seconds) 
% 
improvement 
T25FW-
before 
(seconds) 
T25FW-after 
(seconds) 
% 
improvement 
01/ 10,3 8,8 14,60% 8,7 9,2 6,20% 
03/ 12,7 12 5,40% 12,7 15,3 -21,00% 
04/ 8,2 7,3 11,30% 6,8 6,9 -1,30% 
05/ 8,4 6,7 20,30% 6 5,9 1,20% 
06/ 7,0 6,7 4,40% 7 6,3 9,90% 
07/ 40,4 31 23,40% 40,6 23,7 41,50% 
08/ 12,9 10,2 20,70% 15 17,7 -17,40% 
09/ 5,3 4,4 16,60% 5,4 5,6 -2,20% 
10/ 6,8 5,9 13,20% 7,3 5,8 20,20% 
11/ 22,1 14,8 33,00% 17,9 19,8 -9,90% 
13/ 26,9 25,1 6,60% 18,5 17,6 4,90% 
14/ 12,7 9,8 23,10% 11,2 13,4 -19,50% 
15/ 16,9 15,6 7,80% 16,6 14,2 14,80% 
16/ 16,2 10,7 33,50% 9,7 12,4 -27,90% 
17/ 15,2 9,4 38,40% 14,6 15,3 -4,70% 
18/ 9,7 10,1 -3,60% 9,7 10,2 -5,40% 
20/ 7,7 7,7 0 8,6 8,4 1,90% 
21/ 9,1 8,7 4,60% 9 8,7 3,90% 
22/ 7,6 7,5 1,20% 6,2 6,4 -2,40% 
23/ 6,2 6,2 0 6,7 7,8 -15,70% 
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Descriptive statistics of the results for the 25-Foot Walk test before and after each 
treatment of acupuncture are shown in Table 9 and Figure 18 (n=20), Table 10 and Figure 
19 (males sample), and Table 11 and Figure 20 (females sample).  
 
 
Table 9: Descriptive analysis of T25FW results before and after each 
acupuncture treatment for the whole sample 
 
 True acupuncture Sham acupuncture 
N=20 
Before 
Treatment 
(seconds) 
After 
treatment 
Before 
treatment 
After 
treatment 
Mean 13,1 10,9 11,9 11,5 
Median 10,0 9,1 9,4 9,7 
Maximum 40,4 31,0 40,6 23,7 
Minimum 5,3 4,4 5,4 5,6 
Standard deviation 8,50 6,56 7,92 5,36 
 
Table 10: Descriptive analysis of T25FW results before and after  
each acupuncture treatment for males sample 
 
 True acupuncture Sham acupuncture 
N=8 Before treatment 
After 
treatment 
Before 
treatment 
After 
treatment 
Mean 8,5 7,7 8,5 9,2 
Median 7,7 7,1 6,9 7,1 
Maximum 12,9 12,0 15,0 17,7 
Minimum 5,3 4,4 5,4 5,6 
Standard deviation 2,83 2,39 3,52 4,66 
 
Table 11: Descriptive analysis of T25FW results before and after  
each acupuncture treatment for females sample 
 
 True acupuncture Sham acupuncture 
N=12 Before treatment 
After 
treatment 
Before 
treatment 
After 
treatment 
Mean 16,2 13,1 14,2 13,1 
Median 14,0 10,0 10,5 12,9 
Maximum 40,4 31,0 40,6 23,7 
Minimum 6,8 5,9 6,8 5,8 
Standard deviation 9,67 7,61 9,26 5,38 
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Figure 18: Mean of the T25FW results (seconds) before and after  
each acupuncture treatment for the whole sample 
 
 
Figure 19: Mean of the T25FW results (seconds) before and after  
each acupuncture treatment for the male sample 
 
 
Figure 20: Mean of the T25FW results (seconds) before and after  
each acupuncture treatment for the female sample 
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The percentage of improvement for each individual with respect to the T25FW when true 
acupuncture was done is shown in Figure 21 and in Figure 22 when sham acupuncture 
was done. 
 
 
Figure 21: Percentage of improvement in the T25FW for true acupuncture 
 
 
Figure 22: Percentage of improvement in T25FW for sham acupuncture 
 
All except three patients improved the performance of the T25FW when true acupuncture 
was done (Figure 21).  Also, we found a mean percentage of improvement of 13.9% when 
considering the sample as a whole. Analysing males and females separately we found 
that for females the mean percentage of improvement was 17.5% and for males it was 
8.6%. 
 
When sham acupuncture was done, although some patients improved the performance of 
the test, we cannot see a positive mean percentage of improvement (Figure 22). 
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To study the differences between the results of the 25-Foot Walk test we applied the 
Wilcoxon test for paired samples (Table 12). As can be seen in Table 12, when true 
acupuncture was done the results before and after treatment were statistically significant 
(p<0.05) for the whole sample, and when we considered males and females separately. In 
none of the cases the results before and after treatment with sham acupuncture were 
statistically significant. 
 
 
Table 12: Results of the Wilcoxon test applied to the analysis of T25FW results 
 
   
 
 
 
 
 
 
 
 
 
 
 
*: Statistically significant (p<0.05) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 True acupuncture Sham acupuncture 
N=20 Before vs After Before vs After 
Significance 0.000* 0.370 
Male sample 
N=8 Before vs After Before vs After 
Significance 0.028* 0.205 
Female sample 
N=12 Before vs After Before vs After 
Significance 0.003* 0.875 
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3.3 Gait assessment before and after acupuncture treatment (Tandem walking test) 
Results of the Tandem walking test (TWT) were measured in seconds. Table 13 shows 
the results obtained before and after true acupuncture and sham acupuncture treatments. 
The corresponding percentage of improvement experienced by each patient is also 
shown. From the 20 patients, 15 could perform the test, while for the other 5 patients it 
was not possible.  
 
Table 13: Results of the Tandem walking test before and after true and sham acupuncture 
treatment 
 
 
Descriptive statistics of the results for the Tandem walking test, before and after each 
treatment of acupuncture, are shown in Table 14 and Figure 23 (n=20), Table 15 and 
Figure 24 (male sample), and Table 16 and Figure 25 (female sample).  
 
 
 
 
 True acupuncture Sham acupuncture 
Identification 
nº 
TWT-Before 
(Secons) 
TWT-After 
(Seconds) 
% 
improvement 
TWT-Before 
(Seconds) 
TWT-After 
(Seconds) 
% 
improvement 
01/ 32,38  16,78  48,20%  23,2  19,34  16,60% 
03/ 58,5  47,12  19,50%  58,5  55,5  5,10% 
04/ 17,18  13,68  20,40%  10,37  12,22  ‐17,80% 
05/ 31,02  21,52  30,60%  22,15  19,65  11,30% 
06/ 22,19  18,42  17,00%  25,56  15,82  38,10% 
07/ ‐  ‐  ‐  ‐  ‐  ‐ 
08/ 23,96  18,7  21,90%  24,66  18,07  26,70% 
09/ 19,87  19,23  3,20%  21,27  20,22  4,90% 
10/ 27,7  23,91  13,70%  32,53  25,05  22,90% 
11/ ‐  ‐  ‐  ‐  ‐  ‐ 
13/ 40,81  28,48  30,20%  19,8  17,4  12,40% 
14/ 33,24  24,85  25,20%  26,41  28,09  ‐6,40% 
15/ ‐  ‐  ‐  ‐  ‐  ‐ 
16/ ‐  ‐  ‐  ‐  ‐  ‐ 
17/ 39,92  19,43  51,30%  29,1  20,3  30% 
18/ 24,57  17,85  27,40%  24,9  25,1  ‐0,80% 
20/ 34,4  28,8  16,20%  28,4  29,4  ‐3,40% 
21/ ‐  ‐  ‐  ‐  ‐  ‐ 
22/ 107,11  40,18  62,50%  40,61  23,45  42,20% 
23/ 23,12  20,77  10,20%  26,3  21,2  19,10% 
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Table 14: Descriptive analysis of Tandem walking results before and after  
each acupuncture treatment for the whole sample 
 
 True acupuncture Sham acupuncture 
N=20 Before treatment 
After 
treatment 
Before 
treatment 
After 
treatment 
Mean 35,7 24,0 27,6 23,4 
Median 31,0 20,8 25,6 20,3 
Maximum 107,1 47,1 58,5 55,5 
Minimum 17,2 13,7 10,4 12,2 
Standard deviation 22,30 9,09 10,76 9,99 
 
Table 15: Descriptive analysis of Tandem walking results before and after  
each acupuncture treatment for the male sample 
 
 True acupuncture Sham acupuncture 
N=8 Before treatment 
After 
treatment 
Before 
treatment 
After 
treatment 
Mean 40,0 26,8 30,9 25,4 
Median 27,5 21,1 25,9 20,7 
Maximum 107,1 47,1 58,5 55,5 
Minimum 19,9 18,4 21,3 15,8 
Standard deviation 29,82 11,04 12,65 12,81 
 
Table 16: Descriptive analysis of Tandem walking results before and after  
each acupuncture treatment for the female sample 
 
 True acupuncture Sham acupuncture 
N=12 Before treatment 
After 
treatment 
Before 
treatment 
After 
treatment 
Mean 30,8 20,7 23,8 21,1 
Median 32,4 19,4 24,9 20,3 
Maximum 40,8 28,5 32,5 28,1 
Minimum 17,2 13,7 10,4 12,2 
Standard deviation 8,42 5,20 7,18 5,43 
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Figure 23: Mean of the Tandem walking test results (seconds) before  
and after each acupuncture treatment for the whole sample 
 
 
Figure 24: Mean of the Tandem walking test results (seconds) before  
and after each acupuncture treatment for the male sample 
 
 
Figure 25: Mean of the Tandem walking test results (seconds) before  
and after each acupuncture treatment for the female sample 
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When we analyse the mean values of the results of the Tandem walking test we can see 
that after true acupuncture treatment, there was an improvement in the performance of 
the test when we consider the whole sample, and also considering male and female 
samples separately. The same situation is observed after sham acupuncture, the mean 
value of the results was lower than before the treatment for the whole sample, and for 
male and female samples. 
 
Figure 26 presents the percentages of improvement with respect to the Tandem walking 
test when true acupuncture was done and Figure 27 presents the results when sham 
acupuncture was done.  
 
 
Figure 26: Percentage of improvement in Tandem walking test for true acupuncture 
 
 
Figure 27: Percentage of improvement in Tandem walking test for sham acupuncture 
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For the whole sample (n=20) we found that when true acupuncture treatment was done, 
the mean of the percentage of improvement was 26,5%. Analysing males and females 
separately we found that for the female sample the mean percentage of improvement was 
30,9% and for the male sample it was 22.6%. When sham acupuncture was done, the 
mean of percentage of improvement was 13.4% when we analysed the whole sample, 
8.1% for the female sample and 18.4% for male sample. 
 
Results obtained when we applied the Wilcoxon test for paired samples to study the 
differences between the results of the Tandem walking test are shown in Table 17. When 
true acupuncture was done, the results before and after treatment were statistically 
significant for the whole sample, and when we considered males and females separately. 
Also, the results before and after treatment with sham acupuncture were statistically 
significant for the whole sample and for male sample, but not for female sample. 
 
Table 17: Results of the Wilcoxon test applied to the analysis of Tandem walking results 
 
 True acupuncture Sham acupuncture 
N=20 Before vs After Before vs After 
Significance 0.001* 0.006* 
Male sample 
N=8 Before vs After Before vs After 
Significance 0.012* 0.017* 
Female sample 
N=12 Before vs After Before vs After 
Significance 0.018* 0.176 
 *: Statistically significant 
 
3.4 MSWS12 test 
It was asked to all patients to answer the survey Multiple Sclerosis Walking Scale 12. But 
in some cases, we only have the answers before and after the first acupuncture treatment 
(true or sham, depending on the group) and after the second treatment of the patient. Due 
to these conditions, in the present work the results of the MSWS12 test will not be 
considered. Nevertheless, based on the obtained answers to the test, a general patients’ 
perception of improvement of symptoms after the true acupuncture treatment was 
reported. Some patients reported more mobility, more energy and also less spasms in the 
day after the treatment what improved their daily life. 
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4. DISCUSSION 
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Clinical manifestations of MS present a great variability and are unpredictable, most of 
them representing causes of disability that lead to severe difficulties in the daily life of 
these patients. Although there are no clinical findings that are unique to MS, some of them 
are highly characteristic of the disease: vision problems, fatigue, weakness, pain, 
spasticity are among them (National Sclerosis Society, 2014). Among these clinical 
manifestations of MS, gait dysfunction represents one of the most debilitating symptoms 
experienced by patients with 85% of them reporting gait impairment as a major limitation 
of their lives, as was previously referred (LaRocca, 2011).  
 
Gait is a complex process involving coordination of multiple systems of the body. Thus, 
several factors, such as weakness and spasticity from pyramidal lesions, loss of co-
orientation from dorsal column, and cerebellar lesions, together with visual and cognitive 
dysfunction, pain, and also environmental and personal factors can contribute to walking 
disability (Pearson et al, 2004). 
 
One of the priorities managing with MS is to define strategies to control the symptoms and 
to prevent secondary complications and increased disability associated with the disease. 
Also, it must take into account that the resulting limitations of the disease are associated 
with strong social and economic impacts. Symptomatic treatment must be carefully 
planned and suitable for each patient as there are possible interactions between 
treatments for specific symptoms. Different pharmacological and non-pharmacological 
approaches may be included, but they always need the active involvement of the patient. 
A reduction of the symptoms not only improves the quality of life of the patients but also 
makes them more active and more involved in the treatment (Pope, 2007).  
 
Acupuncture has a wide range of possible applications and may be able to contribute to 
the management of some of the symptoms in patients with MS. Moreover, in general, side 
effects from acupuncture are low. It therefore represents a useful therapeutic option to 
consider within the overall management of individuals with MS. Scientific literature 
regarding the application of acupuncture in neurological diseases has reported reduction 
of pain, numbness and tingling (Schroder et al, 2007; Rapson el al, 2003); significant 
improvement in sensory and motor function (Wong et al, 2003); less spasticity (Liu et al, 
2008); enhanced motor function (Chae et al, 2009); and significant improvement in fatigue 
(Martin et al, 2006; Vickers et al, 2004). However, literature regarding gait impairment is 
scarce, and therefore additional studies using appropriated outcome measures are 
required. 
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Taking this into account, the present study of acupuncture treatment, according to the 
Heidelberg model of TCM, was designed to investigate if acupuncture can be a useful 
therapeutic option in patients with gait impairment in multiple sclerosis of relapse-remitting 
type. To achieve this goal a sample of 20 patients was analysed.  
 
Regarding the characterization of the sample, we found a ratio female/male of 1.5, which 
is in agreement with what was reported in other studies (Ascherio et Munger, 2007). Also, 
differences in the mean age between males and females were found, with a mean age of 
females (50.9) higher than the mean age for males (39.3). In relation to the age at 
diagnosis, we also observed differences: 40.1 years for females and 27.4 years for males. 
This data does not differ from those reported in the outpatient clinic of Braga Hospital with 
235 patients enrolled (Figueiredo et al. 2012), suggesting that although our sample is 
small, 20 individuals, it is representative of the MS population in Portugal.  
 
The patients of our sample were divided into two randomized groups. Each patient 
received in a first moment one acupuncture treatment (true or sham acupuncture) and in a 
second moment the other treatment. Thus, our results refer to paired samples. The time 
interval between the first and the second treatment was, at least, of two weeks. This 
period of time is important to avoid that results from the first treatment interfere in the 
second one.  
 
According to the Heidelberg model of Traditional Chinese Medicine, the pathogenesis of 
MS involves lack of fluids, Yin and Yang deficiency and labile Qi, with the presence of 
stage II, VI and I of ALT. This model was used to select the points for acupuncture 
treatments. Thus, the selected points for true acupuncture - S34 (ST34), V40 (Bl40) and 
V57(Bl57) - are believed to have an effect directed to produce an increasing of Qi and Xue 
flow in lower limbs. They are used in cases of Yin and also Yang deficiency with the 
presence of ventus internus, and they are also considered to be important to dispel humor 
(Greten, 2012). Sham acupuncture was administered away of those points. Frequent 
problems in research of acupuncture have to do with finding an adequate control group 
(Hopwood, 2004) and distinguish how much of the total effect may be represented by the 
associated context/spontaneous effects and how much is attributable to the effect of the 
therapy. In this context the use of paired samples offers the benefit of controlling 
extraneous factors that can influence the results. 
 
For the evaluation of the treatment in terms of gait improvement, we used the 25-Foot 
test. Although assessing gait disability is of great importance in some pathology including 
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MS, there is no consensus regarding the most appropriate tool for characterization of gait 
dysfunction (Kieseier and Pozzilli, 2012). Timed walking over a fixed distance has been 
extensively used as a clinical measure of gait in a variety of neurological conditions and 
forms part of a recommended outcome measure for clinical trials in multiple sclerosis 
(Fisher et al, 1999). In the present study we used the T25FW, the most common of timed 
performance tests. It represents a good measure of overall walking ability and is suited for 
use in clinical setting (Gijbels et al, 2012). In this sense, the results obtained in the present 
study can support the idea that the T25FW test is sufficiently sensitive to changes that 
occurred as a result of treatment and can therefore be a useful tool as a clinical measure 
of gait in studies involving acupuncture. This is an important aspect as well designed 
research is required to guide practice more effectively, and appropriated outcome 
measures (objective and measurable parameters) need to be carefully considered in order 
to contribute to the credibility of the effectiveness of acupuncture treatments. 
 
With respect to the evaluation of the acupuncture treatments, our results reveal a 
statistically significant reduction in the time spent to perform the 25-Foot test with true 
acupuncture treatment when compared to sham acupuncture. These observations must 
be confirmed in future larger trials, but our results produce evidences that the treatment 
protocol used in our study for true acupuncture is more effective in improving gain 
impairment than sham acupuncture. When we observed the percentages of improvement, 
we found a mean improvement value of the order of 14%. When analysing the results by 
gender, it seems that the effect of true acupuncture is stronger in females than in males. 
When we observed the main complains of female sample, disbalance and tiredness are 
the main ones, while males present more variability. We cannot forget that several factors 
influence the individual gait and it is important to remind that TCM diagnosis and 
treatment is based on a different understanding of illness and health from Western 
medicine. Although for acupuncture research standardized protocols are necessary, in 
fact, acupuncture treatments have to be individualized to the patient’s underlying situation.  
 
When using the tandem walking method to evaluate the effectiveness of acupuncture, we 
found statistically significant differences between the time spent to perform the test before 
and after the treatment in both, true acupuncture and sham acupuncture, for the whole 
sample and for male sample, but not for female sample. Walking in a straight line using 
tandem gait brings out abnormalities in gait and balance. As mentioned previously, the 
females of our sample seem to be more affected by disbalance than males, and this fact 
can influence the results. Also, our results seem to point to the possibility that balance 
may depend more on individual motivation or expectations.  
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According to Xia et al (2010) the physiological effects of needling, the distance from the 
classical acupuncture points, as well as a wide range of neurophysiological and 
neurochemical responses, such as the release of neurotransmitters or activation of 
segmental and heterosegmental antinociceptive system, or, the placebo effects, are 
considered to be involved in the improvement of symptoms observed with sham 
acupuncture in some studies. In fact, the placebo effect remains an interesting topic of 
research. Recently, a systematic review estimated the percentage of responders after 
various placebo interventions in studies assessing prophylactic treatment for migraine. 
The authors reported that after oral, pharmacologic placebos, 22% of the patients 
reported an attack frequency reduction greater than 50% and that after sham acupuncture 
this percentage was 38%. (Craen, 2014).  
 
The comparison of our results with those of literature, revealed to be a difficult task 
because of the lack of studies regarding gait and acupuncture in MS. In a recent review 
(Karpatkin et al, 2014) including all studies that used acupuncture to treat any symptom of 
MS or to evaluate disease activity, fifteen articles were found, and none of them 
specifically examined mobility measures such as gait or balance. Five studies examined 
the effect of acupuncture in quality of life, three looked for the effects of acupuncture on 
MS fatigue, two examined the effect of acupuncture in MS spasticity, two examined the 
effect of acupuncture in MS pain and three were animal studies.  
 
The results obtained in the majority of papers regarding MS symptoms point in general to 
beneficial effects of acupuncture. Also, in another review concerning the use of 
complementary therapies in MS, including acupuncture (Esmonde and Long, 2008), MS 
patients described it as generally relaxing, but also a treatment which increased their 
energy and feelings of well-being. More specifically, they said it reduced pain, increased 
flexibility, improved balance and reduced recovery time from relapses. Nevertheless, not 
all the studies show that acupuncture had a meaningful impact on MS. This can be 
explained by the fact that many of the studies are case reports, and others have no 
randomization, adequate measures, poor statistics and little use of controls (Karpatkin et 
al, 2014). 
 
Given the individualized nature of acupuncture treatment, according to TCM, and the 
multifactorial nature of MS, creating appropriated research protocols can be particularly 
challenging (Karpatkin et al, 2014). Individualized acupuncture treatments, contrarily to 
the standard treatments used in randomized clinical trials, the fact that placebo response 
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cannot be neglected and that acupuncture is a complex intervention in physiological 
terms, makes that it does not fit easily into conventional drug trial format. To our 
knowledge, this is the first controlled clinical trial on the effects of acupuncture on gait 
problems in MS patients. Although our results must be interpreted carefully, mainly due to 
small sample size, we found consistent improvement on mobility in patients with MS of 
relapse-remitting type when true acupuncture treatment was used, relative to sham 
acupuncture. 
 
In summary, our study protocol provides evidence that acupuncture treatment, according 
to Heidelberg model of TCM, can result in improvements in mobility in MS population and 
consequently improvement in their quality of life. Of course, larger studies are needed to 
confirm the clinical and cost-effectiveness of acupuncture treatment, but our results 
suggest that acupuncture can be an attractive option for intervention for MS patients with 
gait impairment symptoms looking for an effective therapy. 
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5. CONCLUSSIONS 
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From the results obtained in the present study we can conclude: 
 
 
1- The T25FW test is sufficiently sensitive to changes that occurred as a result of 
treatment and so can be a useful tool as a clinical measure of gait in studies involving 
acupuncture. 
 
2- The Tandem walking test results can possible indicate that balance may depend more 
on individual motivation or expectations.  
 
3- True acupuncture protocol used is more effective in improving gain impairment than 
sham acupuncture, suggesting a specific effect of true acupuncture protocol. 
 
4- Possible differences in factors influencing gait problems can be involved in differences 
in improvement observed between females and males, what may indicates the importance 
of TCM diagnostic and individualized acupuncture treatments according to it. 
 
5- Acupuncture treatment, according to the Heidelberg model of TCM, can result in 
improvements in mobility in MS population and consequently improvement in their quality 
of life.  
 
6- Acupuncture can be an attractive option for intervention for patients with MS of relapse-
remitting type with gait impairment symptoms looking for an effective therapy. 
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